syndrome	score	normalized_score
VITAMIN D-DEPENDENT RICKETS, TYPE 2B, WITH NORMAL VITAMIN D RECEPTOR	1.3749997	100.0
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	1.01071948	73.50688731059358
#158350 COWDEN SYNDROME 1; CWS1;;CS; CD;;MULTIPLE HAMARTOMA SYNDROME; MHAMDYSPLASTIC GANGLIOCYTOMA OF THE CEREBELLUM, INCLUDED;;CEREBELLOPARENCHYMAL DISORDER VI, INCLUDED; CPD6, INCLUDED;;CEREBELLAR GRANULE CELL HYPERTROPHY AND MEGALENCEPHALY, INCLUDED;;LHERMITTE-DUCLOS DISEASE, INCLUDED; LDD, INCLUDED;;PROTEUS-LIKE SYNDROME, INCLUDED	1.0	72.72728859504478
NEPHROTIC SYNDROME, TYPE 1; NPHS1	1.0	72.72728859504478
TRICHOHEPATOENTERIC SYNDROME 1	0.51361532	37.353849604476274
MECKEL SYNDROME, TYPE 1; MKS1	0.50943477	37.049809538140266
ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD11B	0.50290698	36.575061070922416
ECTODERMAL DYSPLASIA 11A, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL DOMINANT; ECTD11A	0.5	36.36364429752239
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.5	36.36364429752239
#226600 EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE; RDEB;;DYSTROPHIC EPIDERMOLYSIS BULLOSA, AUTOSOMAL RECESSIVE;;EPIDERMOLYSIS BULLOSA DYSTROPHICA, HALLOPEAU-SIEMENS TYPE; EBR1EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE, LOCALISATAVARIANT, INCLUDED;;EPIDERMOLYSIS BULLOSA DYSTROPHICA INVERSA, AUTOSOMAL RECESSIVE, INCLUDED	0.5	36.36364429752239
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.3529408	25.66842741856598
CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	0.333333	24.242405289252062
CYSTINOSIS, NEPHROPATHIC; CTNS	0.25384615	18.461542209791027
HYPERPARATHYROIDISM 2	0.25	18.181822148761196
DYSTONIA 6, TORSION	0.25	18.181822148761196
#215400 CHORDOMA, SUSCEPTIBILITY TO; CHDM	0.25	18.181822148761196
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	18.181822148761196
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.2494792	18.1439457768609
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.20381679	14.823042506845638
#600802 SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE,B CELL-POSITIVE, NK CELL-NEGATIVE;;SCID, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-NEGATIVE	0.2	14.545457719008958
PYLE DISEASE; PYL	0.2	14.545457719008958
#606764 GASTROINTESTINAL STROMAL TUMOR; GIST	0.2	14.545457719008958
COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE	0.2	14.545457719008958
#615279 CARDIOFACIOCUTANEOUS SYNDROME 3; CFC3	0.2	14.545457719008958
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.2	14.545457719008958
OSTEOGENESIS IMPERFECTA, TYPE IV	0.2	14.545457719008958
#266600 INFLAMMATORY BOWEL DISEASE 1; IBD1REGIONAL ENTERITIS, INCLUDED;;CROHN DISEASE, INCLUDED;;ULCERATIVE COLITIS, INCLUDED;;CROHN DISEASE-ASSOCIATED GROWTH FAILURE, SUSCEPTIBILITY TO, INCLUDED	0.2	14.545457719008958
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.12884615	9.370631135410429
#500009 MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT; MMIT;;MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT, DUE TO RESPIRATORY CHAINDEFICIENCY;;COX DEFICIENCY MYOPATHY, INFANTILE, TRANSIENT;;RESPIRATORY CHAIN DEFICIENCY, INFANTILE, TRANSIENT	0.125	9.090911074380598
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.125	9.090911074380598
CARNITINE DEFICIENCY, MYOPATHIC	0.125	9.090911074380598
#611283 ISOBUTYRYL-CoA DEHYDROGENASE DEFICIENCY;;IBD DEFICIENCY;;ACYL-CoA DEHYDROGENASE FAMILY, MEMBER 8, DEFICIENCY OF;;ACAD8 DEFICIENCY	0.125	9.090911074380598
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE	0.125	9.090911074380598
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.125	9.090911074380598
3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY; HMGCLD	0.125	9.090911074380598
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.125	9.090911074380598
HYPOPHOSPHATEMIC RICKETS, X-LINKED RECESSIVE	0.125	9.090911074380598
OSTEOGENESIS IMPERFECTA, TYPE X	0.1078125	7.840910801653266
CHOPS SYNDROME; CHOPS	0.10561798	7.681309312285668
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.10384615000000001	7.55244892053431
BLOOM SYNDROME	0.10381679	7.55031364734116
#170100 PROLIDASE DEFICIENCY	0.10290698000000001	7.484145632904503
IMMUNODEFICIENCY 52; IMD52	0.1	7.272728859504479
CILIARY DYSKINESIA, PRIMARY, 39; CILD39	0.1	7.272728859504479
#614700 IMMUNODEFICIENCY, COMMON VARIABLE, 8, WITH AUTOIMMUNITY; CVID8	0.1	7.272728859504479
CYSTIC FIBROSIS	0.1	7.272728859504479
IMMUNODEFICIENCY 57; IMD57	0.1	7.272728859504479
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.09114580000000001	6.628786900826233
HYPOPHOSPHATEMIC RICKETS AND HYPERPARATHYROIDISM	0.08717945000000002	6.3403250197072785
#307800 HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT; XLHR;;HYPOPHOSPHATEMIA, X-LINKED; XLH;;HYP;;VITAMIN D-RESISTANT RICKETS, X-LINKED;;HYPOPHOSPHATEMIC VITAMIN D-RESISTANT RICKETS; HPDR	0.08717945000000002	6.3403250197072785
ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1	0.08333330000000001	6.060604958677446
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 2; ARHR2	0.08333330000000001	6.060604958677446
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT	0.08333330000000001	6.060604958677446
#614473 ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2; GACI2	0.08333330000000001	6.060604958677446
TYROSINEMIA, TYPE I; TYRSN1	0.08333330000000001	6.060604958677446
POTOCKI-LUPSKI SYNDROME	0.0611888	4.450095516384477
#214700 DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL; DIAR1;;CHLORIDE DIARRHEA, CONGENITAL, FINNISH TYPE;;CHLORIDORRHEA, CONGENITAL	0.0588697	4.281433661403708
KAGAMI-OGATA SYNDROME	0.05238711	3.8099724676303564
SILVER-RUSSELL SYNDROME; SRS	0.05207682	3.7874059172522005
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.05176987	3.765082276017951
YUNIS-VARON SYNDROME	0.04978517	3.6207404263433656
#613388 FANCONI RENOTUBULAR SYNDROME 2; FRTS2	0.049479199999999994	3.59848805785194
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.04945077	3.596420421037182
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.048753479999999995	3.5457084099727436
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.048753479999999995	3.5457084099727436
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.047630900000000004	3.4640662103417186
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.045512849999999994	3.310026176732984
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.045512849999999994	3.310026176732984
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.045512849999999994	3.310026176732984
#206920 MICROPHTHALMIA WITH LIMB ANOMALIES;;WAARDENBURG ANOPHTHALMIA SYNDROME;;ANOPHTHALMIA-SYNDACTYLY;;OPHTHALMOACROMELIC SYNDROME; OAS	0.045214630000000006	3.2883374447281697
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.04493679	3.268130894864922
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.04408799	3.206399972305449
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.0423351	3.0789170354000808
ADAMS-OLIVER SYNDROME 5; AOS5	0.0423351	3.0789170354000808
ACRORENAL-MANDIBULAR SYNDROME	0.04227829	3.074785398134996
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.0419606	3.051680665821236
RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA	0.041666699999999994	3.030306115703152
LOWE OCULOCEREBRORENAL SYNDROME	0.041666699999999994	3.030306115703152
#607748 HYPERCHOLANEMIA, FAMILIAL; FHCA	0.041666699999999994	3.030306115703152
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.041666699999999994	3.030306115703152
RENAL TUBULAR ACIDOSIS III	0.041666699999999994	3.030306115703152
FANCONI RENOTUBULAR SYNDROME 1; FRTS1	0.041666699999999994	3.030306115703152
#615605 FANCONI RENOTUBULAR SYNDROME 3; FRTS3	0.041666699999999994	3.030306115703152
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.041666699999999994	3.030306115703152
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1; CBAS1	0.041666699999999994	3.030306115703152
DENT DISEASE 1	0.041666699999999994	3.030306115703152
HYPOPHOSPHATASIA, ADULT	0.041666699999999994	3.030306115703152
HYPOPHOSPHATEMIC BONE DISEASE	0.041666699999999994	3.030306115703152
FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4	0.041666699999999994	3.030306115703152
#219900 CYSTINOSIS, LATE-ONSET JUVENILE OR ADOLESCENT NEPHROPATHIC TYPE;;CYSTINOSIS, INTERMEDIATE	0.041666699999999994	3.030306115703152
#267000 PERLMAN SYNDROME; PRLMNS;;RENAL HAMARTOMAS, NEPHROBLASTOMATOSIS, AND FETAL GIGANTISM;;NEPHROBLASTOMATOSIS, FETAL ASCITES, MACROSOMIA, AND WILMS TUMOR	0.04136848	3.008617383698338
CHROMOSOME 1P36 DELETION SYNDROME	0.04105079	2.985512651384578
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.04018083	2.9222428193984333
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.04005625	2.9131824537852626
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.040015999999999996	2.9102551804193117
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0384615	2.797200610298315
COWDEN SYNDROME 5; CWS5	0.0384615	2.797200610298315
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0384615	2.797200610298315
HYPOADRENOCORTICISM, FAMILIAL	0.0384615	2.797200610298315
PREPAPILLARY VASCULAR LOOPS	0.0384615	2.797200610298315
ATROPHODERMA VERMICULATA; AVA	0.0384615	2.797200610298315
VENULAR INSUFFICIENCY, SYSTEMIC	0.0384615	2.797200610298315
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.0384615	2.797200610298315
%113950 BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT	0.0384615	2.797200610298315
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.0384615	2.797200610298315
THUMB DEFORMITY	0.0384615	2.797200610298315
WATSON SYNDROME	0.0384615	2.797200610298315
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.0384615	2.797200610298315
ARTERIES, ANOMALIES OF	0.0384615	2.797200610298315
HEMANGIOPERICYTOMA, MALIGNANT	0.0384615	2.797200610298315
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.0384615	2.797200610298315
#608358 MYOPATHY, MYOSIN STORAGE;;MYOPATHY, HYALINE BODY, AUTOSOMAL DOMINANT	0.0384615	2.797200610298315
MUSCULAR HYPERTONIA, LETHAL	0.0384615	2.797200610298315
COWDEN SYNDROME 6; CWS6	0.0384615	2.797200610298315
BETHLEM MYOPATHY 1	0.0384615	2.797200610298315
OSTEOPENIA AND SPARSE HAIR	0.0381155	2.772036968444429
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.037931290000000006	2.7586398746123364
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.03729293	2.7122136826648036
HARDIKAR SYNDROME	0.03727385	2.71082604599841
HYPERTELORISM AND TETRALOGY OF FALLOT	0.037204640000000004	2.7057925903547475
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.03720464	2.7057925903547466
BEEMER LETHAL MALFORMATION SYNDROME	0.0371517	2.7019424076965253
15q24 recurrent microdeletion syndrome	0.03625538	2.6367554843830145
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.03592098	2.6124354790768316
RESTRICTIVE DERMOPATHY, LETHAL	0.03579535	2.603298749810636
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.03509841	2.5526121932972057
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.03509841	2.5526121932972057
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.03509841	2.5526121932972057
TRANSALDOLASE DEFICIENCY	0.035069050000000004	2.550476920104056
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig; CDG1G	0.03429766	2.4943758169547237
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.03415435	2.4839532692261677
ALVEOLAR CAPILLARY DYSPLASIA WITH MISALIGNMENT OF PULMONARY VEINS; ACDMPV	0.03415435	2.4839532692261677
MENKES DISEASE	0.03411979	2.481439814132323
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.03219143	2.3411954198971823
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.03216207	2.339060146704032
#256520 NEU-LAXOVA SYNDROME; NLS	0.03216207	2.339060146704032
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.03216207	2.339060146704032
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.03206685	2.3321350542840116
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.032021240000000006	2.328817962651192
MARSHALL-SMITH SYNDROME; MRSHSS	0.03197891	2.3257394165249634
FONTAINE PROGEROID SYNDROME; FPS	0.03194955	2.323604143331813
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.03165587	2.3022455932172203
CARDIAC VALVULAR DEFECT, DEVELOPMENTAL; CVDD	0.03165587	2.3022455932172203
CHROMOSOME 14q11-q22 DELETION SYNDROME	0.031252260000000004	2.2728921322673745
TIMOTHY SYNDROME; TS	0.031252260000000004	2.2728921322673745
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.03125226	2.272892132267374
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.03115922	2.2661255853364914
TEMPLE SYNDROME	0.030978119999999998	2.2529546733719283
DWARFISM, LEVI TYPE	0.030302999999999997	2.2038550262956416
EDINBURGH MALFORMATION SYNDROME	0.030302999999999997	2.2038550262956416
NASAL GROOVE, FAMILIAL TRANSVERSE	0.030302999999999997	2.2038550262956416
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.030302999999999997	2.2038550262956416
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.030302999999999997	2.2038550262956416
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.030302999999999997	2.2038550262956416
OROFACIAL CLEFT 3	0.030302999999999997	2.2038550262956416
#230600 GM1-GANGLIOSIDOSIS, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, JUVENILE TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 2GANGLIOSIDOSIS, GENERALIZED GM1, LATE-INFANTILE TYPE, INCLUDED	0.030302999999999997	2.2038550262956416
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.030302999999999997	2.2038550262956416
22q11.2 distal deletion syndrome	0.030302999999999997	2.2038550262956416
DIMPLES, FACIAL	0.030302999999999997	2.2038550262956416
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.030302999999999997	2.2038550262956416
NASAL ALAR COLLAPSE, BILATERAL	0.030302999999999997	2.2038550262956416
#128200 EPISODIC KINESIGENIC DYSKINESIA 1; EKD1;;PAROXYSMAL KINESIGENIC CHOREOATHETOSIS; PKC;;PAROXYSMAL KINESIGENIC DYSKINESIA; PKD;;DYSTONIA, FAMILIAL PAROXYSMAL;;DYSTONIA 10; DYT10	0.030302999999999997	2.2038550262956416
CYANIDE, INABILITY TO SMELL	0.030302999999999997	2.2038550262956416
#219100 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IA; ARCL1A;;ARCL1;;CUTIS LAXA, AUTOSOMAL RECESSIVE	0.030302999999999997	2.2038550262956416
#230650 GM1-GANGLIOSIDOSIS, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, ADULT TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, CHRONIC TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 3	0.030302999999999997	2.2038550262956416
WAARDENBURG SYNDROME, TYPE IIB	0.030302999999999997	2.2038550262956416
15q13.3 microdeletion syndrome	0.030302999999999997	2.2038550262956416
NASAL BONES, ABSENCE OF	0.030302999999999997	2.2038550262956416
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.030302999999999997	2.2038550262956416
#604367 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3; FPLD3;;LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH PPARG MUTATIONS	0.030302999999999997	2.2038550262956416
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.030302999999999997	2.2038550262956416
Growth hormone deficiency, isolated, type IA	0.030302999999999997	2.2038550262956416
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.030302999999999997	2.2038550262956416
SPEECH-LANGUAGE DISORDER 1	0.030302999999999997	2.2038550262956416
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.030302999999999997	2.2038550262956416
CLEFT CHIN	0.030302999999999997	2.2038550262956416
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.030302999999999997	2.2038550262956416
KOOLEN-DE VRIES SYNDROME; KDVS	0.030289260000000002	2.202855753350346
TARP SYNDROME; TARPS	0.030289260000000002	2.202855753350346
WITTEVEEN-KOLK SYNDROME	0.030220050000000002	2.1978222977066832
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.03017737	2.1947182970294463
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.03017737	2.1947182970294463
FIBROCHONDROGENESIS 1; FBCG1	0.02948043	2.144031740516016
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.02948043	2.144031740516016
CAMPOMELIC DYSPLASIA	0.02937945	2.1366877389136887
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.029042570000000004	2.11218736993179
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.028536370000000002	2.075372816444978
MELNICK-NEEDLES SYNDROME	0.028536370000000002	2.075372816444978
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.02834528	2.0614753588673507
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.02834528	2.0614753588673507
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.02834528	2.0614753588673507
RIGHT PULMONARY ARTERY, ANOMALOUS ORIGIN OF, FAMILIAL	0.02834528	2.0614753588673507
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.02834528	2.0614753588673507
#225410 EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL RECESSIVE;;EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE;;DERMATOSPARAXIS;;EDS VIIC;;EDS7C	0.028220699999999998	2.0524149932541804
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.028220699999999998	2.0524149932541804
INFANTILE SIALIC ACID STORAGE DISEASE	0.028220699999999998	2.0524149932541804
PETERS-PLUS SYNDROME; PTRPLS	0.02816187	2.048136446866134
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.02734243	1.9885407974998104
ACROCALLOSAL SYNDROME; ACLS	0.02734243	1.9885407974998104
COFFIN-SIRIS SYNDROME 1; CSS1	0.027222700000000002	1.9798331592363259
ATELOSTEOGENESIS, TYPE I; AO1	0.027161329999999997	1.9753698855352477
GAUCHER DISEASE, PERINATAL LETHAL	0.02713197	1.973234612342097
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.02657345	1.9326149671159927
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.02654409	1.9304796939228424
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg; CDG2G	0.02651024	1.9280178752039
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.02651024	1.9280178752039
VACTERL ASSOCIATION, X-LINKED, WITH OR WITHOUT HYDROCEPHALUS; VACTERLX	0.02647247	1.9252709655136653
15q26 overgrowth syndrome	0.02647247	1.9252709655136653
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.02647247	1.9252709655136653
#236700 MCKUSICK-KAUFMAN SYNDROME; MKKS;;HYDROMETROCOLPOS SYNDROME;;HYDROMETROCOLPOS, POSTAXIAL POLYDACTYLY, AND CONGENITAL HEART MALFORMATION;HMCS;;KAUFMAN-MCKUSICK SYNDROME	0.02647247	1.9252709655136653
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.02636093	1.917158963743774
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.02636093	1.917158963743774
KNIEST-LIKE DYSPLASIA, LETHAL	0.026026179999999996	1.8928135038865823
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.026026179999999996	1.8928135038865823
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.02563428	1.8643116794861845
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.0253564	1.8441022205313937
FRANK-TER HAAR SYNDROME; FTHS	0.0253564	1.8441022205313937
CHROMOSOME 17q23.1-q23.2 DELETION SYNDROME	0.025225780000000003	1.834602582095109
MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME	0.025225780000000003	1.834602582095109
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.02520684	1.8332251272491187
#192350 VATER ASSOCIATIONVACTERL ASSOCIATION, INCLUDED	0.02431572	1.7684163858363022
%300712 CRANIOFACIOSKELETAL SYNDROME	0.02431572	1.7684163858363022
ZTTK SYNDROME; ZTTKS	0.02429703	1.767057112812461
COFFIN-SIRIS SYNDROME 4; CSS4	0.02426767	1.7649218396193105
COFFIN-SIRIS SYNDROME 3; CSS3	0.02426767	1.7649218396193105
ROIFMAN SYNDROME; RFMN	0.02422499	1.7618178389420738
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.02422499	1.7618178389420738
TYSHCHENKO SYNDROME	0.02422499	1.7618178389420738
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.02422499	1.7618178389420738
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.02422499	1.7618178389420738
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.02422499	1.7618178389420738
Diamond-Blackfan anemia 1	0.02422499	1.7618178389420738
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.02422499	1.7618178389420738
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.02422499	1.7618178389420738
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.02422499	1.7618178389420738
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.02349628	1.7088207364699788
CRI-DU-CHAT SYNDROME	0.02349628	1.7088207364699788
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.02349628	1.7088207364699788
HALLERMANN-STREIFF SYNDROME; HSS	0.02345395	1.7057421903437504
#259420 OSTEOGENESIS IMPERFECTA, TYPE III;;OI, TYPE III;;OI3;;OSTEOGENESIS IMPERFECTA, PROGRESSIVELY DEFORMING, WITH NORMAL SCLERAE	0.02345395	1.7057421903437504
STUVE-WIEDEMANN SYNDROME	0.02345395	1.7057421903437504
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.023424590000000002	1.7036069171506
COSTELLO SYNDROME; CSTLO	0.023315179999999998	1.6956498245054161
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.023161880000000003	1.684500731163796
EVEN-PLUS SYNDROME	0.0227273	1.6528949060861613
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.0227273	1.6528949060861613
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.0227273	1.6528949060861613
LOEYS-DIETZ SYNDROME 5	0.0227273	1.6528949060861613
#611363 ATRIAL SEPTAL DEFECT 4; ASD4	0.0227273	1.6528949060861613
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.02251478	1.6374389027139427
HURLER-SCHEIE SYNDROME	0.02251478	1.6374389027139427
#304120 OTOPALATODIGITAL SYNDROME, TYPE II; OPD2;;OPD II SYNDROME;;OPD SYNDROME 2;;CRANIOORODIGITAL SYNDROME;;FACIOPALATOOSSEOUS SYNDROME; FPO	0.02163408	1.5733879796482866
RITSCHER-SCHINZEL SYNDROME 1	0.02160472	1.571252706455136
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.02142782	1.5583872491026725
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.02136069	1.553505066219287
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.02129968	1.5490679743421034
PALLISTER-HALL SYNDROME	0.02127032	1.5469327011489529
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.02049893	1.4908315979996212
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.02049893	1.4908315979996212
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.02045088	1.4873370517826294
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.02045088	1.4873370517826294
WHITE-SUTTON SYNDROME; WHSUS	0.02045088	1.4873370517826294
241800 HYPOTHALAMIC HAMARTOMASCONGENITAL HYPOTHALAMIC HAMARTOMA SYNDROME, INCLUDED; CHHS, INCLUDED	0.02045088	1.4873370517826294
OHDO SYNDROME	0.02045088	1.4873370517826294
COFFIN-SIRIS SYNDROME 2; CSS2	0.02045088	1.4873370517826294
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.020408199999999998	1.4842330511053927
#609152 HYPERTHYROIDISM, NONAUTOIMMUNE;;HYPERTHYROIDISM, CONGENITAL NONAUTOIMMUNE;;HYPERTHYROIDISM, NONAUTOIMMUNE, AUTOSOMAL DOMINANT;;TOXIC THYROID HYPERPLASIA, AUTOSOMAL DOMINANT	0.020408199999999998	1.4842330511053927
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.020408199999999998	1.4842330511053927
#242500 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4B; ARCI4B;;ICHTHYOSIS CONGENITA, HARLEQUIN FETUS TYPE;;HARLEQUIN ICHTHYOSIS; HI;;'HARLEQUIN FETUS'	0.020408199999999998	1.4842330511053927
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.020408199999999998	1.4842330511053927
NEMALINE MYOPATHY 10	0.020408199999999998	1.4842330511053927
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.020408199999999998	1.4842330511053927
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.020408199999999998	1.4842330511053927
#267450 RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS;;RDS OF PREMATURITY;;HYALINE MEMBRANE DISEASE, FORMERLY	0.020408199999999998	1.4842330511053927
CORNEODERMATOOSSEOUS SYNDROME	0.020408199999999998	1.4842330511053927
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.020408199999999998	1.4842330511053927
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.020408199999999998	1.4842330511053927
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.020408199999999998	1.4842330511053927
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.020408199999999998	1.4842330511053927
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.020408199999999998	1.4842330511053927
#215045 CHONDRODYSPLASIA, BLOMSTRAND TYPE; BOCD	0.020408199999999998	1.4842330511053927
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.020408199999999998	1.4842330511053927
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0196078	1.4260221293139193
PACHYDERMODACTYLY, FAMILIAL	0.0196078	1.4260221293139193
#212840 CEREBELLAR ATAXIA AND HYPOGONADOTROPIC HYPOGONADISM; CAHH;;GORDON HOLMES SYNDROME;;LUTEINIZING HORMONE-RELEASING HORMONE, DEFICIENCY OF, WITH ATAXIA;;LHRH DEFICIENCY AND ATAXIA	0.0196078	1.4260221293139193
PULMONARY HYPERTENSION, PRIMARY, 4	0.0196078	1.4260221293139193
TRACHEOBRONCHOMEGALY	0.0196078	1.4260221293139193
#234810 PULMONARY VENOOCCLUSIVE DISEASE 2, AUTOSOMAL RECESSIVE; PVOD2;;HEMANGIOMATOSIS, FAMILIAL PULMONARY CAPILLARY	0.0196078	1.4260221293139193
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.0196078	1.4260221293139193
ATRIOVENTRICULAR SEPTAL DEFECT 3; AVSD3	0.0196078	1.4260221293139193
DOUBLE NAIL FOR FIFTH TOE	0.0196078	1.4260221293139193
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0196078	1.4260221293139193
TRACHEOPATHIA OSTEOPLASTICA	0.0196078	1.4260221293139193
#178600 PULMONARY HYPERTENSION, PRIMARY, 1; PPH1;;PHT;;PULMONARY ARTERIAL HYPERTENSION; PAHPULMONARY HYPERTENSION, PRIMARY, DEXFENFLURAMINE-ASSOCIATED, INCLUDED;;PULMONARY HYPERTENSION, PRIMARY, FENFLURAMINE-ASSOCIATED, INCLUDED;;PULMONARY HYPERTENSION, PRIMARY, 1, WITH HEREDITARY HEMORRHAGIC TELANGIECTASIA,INCLUDED;;PPH1 WITH HHT, INCLUDED	0.0196078	1.4260221293139193
248100 MACROSOMIA ADIPOSA CONGENITA	0.0196078	1.4260221293139193
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.0196078	1.4260221293139193
GAUCHER DISEASE, TYPE I	0.0196078	1.4260221293139193
#614651 COENZYME Q10 DEFICIENCY, PRIMARY, 2; COQ10D2	0.0196078	1.4260221293139193
#215300 CHONDROSARCOMA	0.0196078	1.4260221293139193
#614185 GELEOPHYSIC DYSPLASIA 2; GPHYSD2	0.0196078	1.4260221293139193
CARDIOMYOPATHY, DILATED, 2C; CMD2C	0.0196078	1.4260221293139193
CIRCUMVALLATE PLACENTA SYNDROME	0.0196078	1.4260221293139193
THROMBOCYTOPENIA 3	0.0196078	1.4260221293139193
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0196078	1.4260221293139193
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.0196078	1.4260221293139193
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.0196078	1.4260221293139193
COPPER DEFICIENCY, FAMILIAL BENIGN	0.0196078	1.4260221293139193
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0196078	1.4260221293139193
GLYCOGEN STORAGE DISEASE Ic; GSD1C	0.0196078	1.4260221293139193
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0196078	1.4260221293139193
LYMPHEDEMA AND CEREBRAL ARTERIOVENOUS ANOMALY	0.0196078	1.4260221293139193
SPINAL ARACHNOIDITIS	0.0196078	1.4260221293139193
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.0196078	1.4260221293139193
CARPAL DISPLACEMENT	0.0196078	1.4260221293139193
MICROPHTHALMIA, SYNDROMIC 4	0.0196078	1.4260221293139193
RAYNAUD DISEASE	0.0196078	1.4260221293139193
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0196078	1.4260221293139193
CIRRHOSIS, FAMILIAL	0.0196078	1.4260221293139193
NEPHROSIALIDOSIS	0.0196078	1.4260221293139193
#615342 PULMONARY HYPERTENSION, PRIMARY, 2; PPH2	0.0196078	1.4260221293139193
PULMONARY VENOOCCLUSIVE DISEASE 1, AUTOSOMAL DOMINANT	0.0196078	1.4260221293139193
TOTAL ANOMALOUS PULMONARY VENOUS RETURN 1	0.0196078	1.4260221293139193
BAND HETEROTOPIA; BH	0.0196078	1.4260221293139193
MONOPHALANGY OF GREAT TOE	0.0196078	1.4260221293139193
PUBIC BONE DYSPLASIA	0.0196078	1.4260221293139193
VESICOURETERAL REFLUX 1	0.0196078	1.4260221293139193
ROWLEY-ROSENBERG SYNDROME	0.0196078	1.4260221293139193
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0196078	1.4260221293139193
THROMBOCYTHEMIA, ESSENTIAL	0.0196078	1.4260221293139193
265400 PULMONARY HYPERTENSION, PRIMARY, AUTOSOMAL RECESSIVE	0.0196078	1.4260221293139193
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.0196078	1.4260221293139193
TOE, MISSHAPEN	0.0196078	1.4260221293139193
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.0196078	1.4260221293139193
#614475 ATRIAL SEPTAL DEFECT 9; ASD9	0.0196078	1.4260221293139193
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0196078	1.4260221293139193
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0196078	1.4260221293139193
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.0196078	1.4260221293139193
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0196078	1.4260221293139193
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0196078	1.4260221293139193
#615422 INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 2; IBMPFD2 ;;MULTISYSTEM PROTEINOPATHY 2; MSP2	0.0196078	1.4260221293139193
#615343 PULMONARY HYPERTENSION, PRIMARY, 3; PPH3	0.0196078	1.4260221293139193
THUMBS, CONGENITAL CLASPED	0.0196078	1.4260221293139193
VAN DEN BOSCH SYNDROME	0.0196078	1.4260221293139193
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.0196078	1.4260221293139193
PULMONARY FIBROSIS, IDIOPATHIC; IPF	0.0196078	1.4260221293139193
HHHH SYNDROME	0.0196078	1.4260221293139193
LETTERER-SIWE DISEASE	0.0196078	1.4260221293139193
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0196078	1.4260221293139193
ADAMS-OLIVER SYNDROME 1; AOS1	0.0196078	1.4260221293139193
THALIDOMIDE SUSCEPTIBILITY	0.0196078	1.4260221293139193
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.0196078	1.4260221293139193
KNUCKLE PADS	0.0196078	1.4260221293139193
MEGAEPIPHYSEAL DWARFISM	0.0196078	1.4260221293139193
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.0196078	1.4260221293139193
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0196078	1.4260221293139193
LYSOSOMAL ACID LIPASE DEFICIENCY	0.0196078	1.4260221293139193
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0196078	1.4260221293139193
#102500 HAJDU-CHENEY SYNDROME; HJCYS;;ACROOSTEOLYSIS WITH OSTEOPOROSIS AND CHANGES IN SKULL AND MANDIBLE;;CHENEY SYNDROME;;ARTHRODENTOOSTEODYSPLASIA;;SERPENTINE FIBULA-POLYCYSTIC KIDNEY SYNDROME; SFPKS	0.019382860000000002	1.4096628530173498
JOHANSON-BLIZZARD SYNDROME; JBS	0.01869774	1.3598359330551126
HYDROLETHALUS SYNDROME 1	0.01869774	1.3598359330551126
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.01836334	1.3355159277489295
PALLISTER-KILLIAN SYNDROME	0.018323489999999998	1.332617745298417
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.01778793	1.293667918618455
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.01778793	1.293667918618455
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC TYPE; AMCN	0.0175439	1.2759202783826062
233430 GONADAL DYSGENESIS, XY TYPE, WITH ASSOCIATED ANOMALIES	0.0175439	1.2759202783826062
SMITH-MAGENIS SYNDROME; SMS	0.0175439	1.2759202783826062
CHROMOSOME 15q13.3 MICRODELETION SYNDROME	0.0175439	1.2759202783826062
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.0175439	1.2759202783826062
FANCONI ANEMIA	0.0175439	1.2759202783826062
FACIOCARDIOMELIC DYSPLASIA, LETHAL	0.0175439	1.2759202783826062
TRISOMY 18-LIKE SYNDROME	0.0175439	1.2759202783826062
#101400 SAETHRE-CHOTZEN SYNDROME; SCS;;ACROCEPHALOSYNDACTYLY, TYPE III; ACS3;;ACS III;;CHOTZEN SYNDROME;;ACROCEPHALY, SKULL ASYMMETRY, AND MILD SYNDACTYLYSAETHRE-CHOTZEN SYNDROME WITH EYELID ANOMALIES, INCLUDED;;BLEPHAROPHIMOSIS, EPICANTHUS INVERSUS, AND PTOSIS 3, FORMERLY, INCLUDED;BPES3, FORMERLY, INCLUDED	0.0175439	1.2759202783826062
AUROCEPHALOSYNDACTYLY	0.0175439	1.2759202783826062
#227646 FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2;;FAD2;;FANCONI ANEMIA, COMPLEMENTATION GROUP D; FANCD; FACD;;FANCONI PANCYTOPENIA, TYPE 4; FA4	0.0175439	1.2759202783826062
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	0.0175439	1.2759202783826062
#136570 CHROMOSOME 16p12.1 DELETION SYNDROME, 520-KBFRAGILE SITE 16p12, INCLUDED	0.0175439	1.2759202783826062
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.0175439	1.2759202783826062
212135 CARDIOSKELETAL SYNDROME, KUWAITI TYPE	0.0175439	1.2759202783826062
BARAITSER-WINTER SYNDROME 2; BRWS2	0.0175439	1.2759202783826062
#227645 FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCC;;FACC; FAC;;FANCONI PANCYTOPENIA, TYPE 3; FA3	0.0175439	1.2759202783826062
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.0175439	1.2759202783826062
CRANIOSTENOSIS, SAGITTAL, WITH CONGENITAL HEART DISEASE, MENTAL DEFICIENCY, AND MANDIBULAR ANKYLOSIS	0.0175439	1.2759202783826062
VACTERL ASSOCIATION WITH HYDROCEPHALUS	0.0175439	1.2759202783826062
184705 STEINFELD SYNDROME	0.0175439	1.2759202783826062
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,AND LETHAL CONGENITAL HEART DISEASE	0.0175439	1.2759202783826062
#218600 BALLER-GEROLD SYNDROME; BGS;;CRANIOSYNOSTOSIS WITH RADIAL DEFECTS;;CRANIOSYNOSTOSIS-RADIAL APLASIA SYNDROME	0.0175439	1.2759202783826062
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.0175439	1.2759202783826062
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.0175439	1.2759202783826062
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.0175439	1.2759202783826062
RECOMBINANT CHROMOSOME 8 SYNDROME	0.017453530000000002	1.269347913312272
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.017453530000000002	1.269347913312272
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.017453530000000002	1.269347913312272
#201000 CARPENTER SYNDROME 1; CRPT1;;CARPENTER SYNDROME;;ACROCEPHALOPOLYSYNDACTYLY TYPE II;;ACPS II	0.017453530000000002	1.269347913312272
Contractural arachnodactyly, congenital	0.01727663	1.2564824559598085
DIAMOND-BLACKFAN ANEMIA 7; DBA7	0.017247270000000002	1.2543471827666581
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.01674107	1.2175326292798465
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.01674107	1.2175326292798465
#610682 OSTEOGENESIS IMPERFECTA, TYPE VII; OI7;;OI, TYPE VII;;OSTEOGENESIS IMPERFECTA, TYPE IIB, FORMERLY; OI2B, FORMERLY	0.01674107	1.2175326292798465
#273750 THREE M SYNDROME 1; 3M1;;3@M SYNDROME;;LE MERRER SYNDROME;;DOLICHOSPONDYLIC DYSPLASIA;;GLOOMY FACE SYNDROMEYAKUT SHORT STATURE SYNDROME, INCLUDED	0.0165223	1.2016220803539084
COHEN-GIBSON SYNDROME; COGIS	0.016337459999999998	1.1881791683300003
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.016337459999999998	1.1881791683300003
ZUNICH NEUROECTODERMAL SYNDROME	0.0156817	1.1404875215609138
CHROMOSOME 17q12 DELETION SYNDROME	0.0156817	1.1404875215609138
#180700 ROBINOW SYNDROME, AUTOSOMAL DOMINANT; DRS;;ROBINOW DWARFISM;;FETAL FACE SYNDROME;;ACRAL DYSOSTOSIS WITH FACIAL AND GENITAL ABNORMALITIES	0.0156817	1.1404875215609138
#268310 ROBINOW SYNDROME, AUTOSOMAL RECESSIVE; RRS;;COSTOVERTEBRAL SEGMENTATION DEFECT WITH MESOMELIA, FORMERLY;;COVESDEM SYNDROME, FORMERLYROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH APLASIA/HYPOPLASIA OFPHALANGES AND METACARPALS/METATARSALS, INCLUDED;;ROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH BRACHY-SYN-POLYDACTYLY,INCLUDED	0.0156817	1.1404875215609138
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.01547544	1.1254867910153
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.01547544	1.1254867910153
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.01541651	1.121200971898394
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.01541651	1.121200971898394
MICROPHTHALMIA, SYNDROMIC 3	0.01541651	1.121200971898394
MIRAGE SYNDROME; MIRAGE	0.01538715	1.1190656987052434
FLOATING-HARBOR SYNDROME	0.01488095	1.0822511452184316
FRYNS SYNDROME; FRNS	0.01488095	1.0822511452184316
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.01488095	1.0822511452184316
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.01488095	1.0822511452184316
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.01456563	1.059318776578642
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.01456563	1.059318776578642
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE; SEMDSP	0.01456563	1.059318776578642
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.01456563	1.059318776578642
3MC SYNDROME 1	0.01454655	1.0579311399122486
#100100 PRUNE BELLY SYNDROME; PBS;;ABDOMINAL MUSCLES, ABSENCE OF, WITH URINARY TRACT ABNORMALITY ANDCRYPTORCHIDISM;;EAGLE-BARRETT SYNDROME; EGBRS	0.01454655	1.0579311399122486
DIGEORGE SYNDROME; DGS	0.01454655	1.0579311399122486
CHARGE SYNDROME	0.01454655	1.0579311399122486
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.01454655	1.0579311399122486
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.01454655	1.0579311399122486
WILLIAMS-BEUREN SYNDROME; WBS	0.01453627	1.0571835033854917
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.01453627	1.0571835033854917
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.01453627	1.0571835033854917
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.01447734	1.0528976842685855
CHROMOSOME 18Q DELETION SYNDROME	0.01447734	1.0528976842685855
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.01447734	1.0528976842685855
CHROMOSOME 9P DELETION SYNDROME	0.01447734	1.0528976842685855
VAN MALDERGEM SYNDROME 2; VMLDS2	0.01376488	1.00108240023616
VAN MALDERGEM SYNDROME 1; VMLDS1	0.01376488	1.00108240023616
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.01361532	0.9902053069538851
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1	0.01343048	0.9767623949299771
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.01343048	0.9767623949299771
TURNPENNY-FRY SYNDROME; TPFS	0.01328092	0.9658853016477021
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.01277472	0.9290707481608904
NIJMEGEN BREAKAGE SYNDROME	0.01274536	0.9269354749677401
MACDERMOT-WINTER SYNDROME	0.01274536	0.9269354749677401
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E	0.01274536	0.9269354749677401
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.01274536	0.9269354749677401
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.01274536	0.9269354749677401
#166250 OSTEOGLOPHONIC DYSPLASIA; OGD;;OSTEOGLOPHONIC DWARFISM	0.01270551	0.9240372925172274
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.01270551	0.9240372925172274
OMODYSPLASIA	0.01270551	0.9240372925172274
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.01267615	0.921902019324077
JACOBSEN SYNDROME	0.01267615	0.921902019324077
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.01267615	0.921902019324077
#614732 INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIACONGENITA, AND GENITAL ANOMALIES;;IMAGE SYNDROME	0.01267615	0.921902019324077
#257300 MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1;;MVA SYNDROME	0.01267615	0.921902019324077
BRANCHIOOCULOFACIAL SYNDROME	0.01267615	0.921902019324077
CORNELIA DE LANGE SYNDROME 1	0.01267615	0.921902019324077
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.01237111	0.8997172872110444
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.01237111	0.8997172872110444
CORNELIA DE LANGE SYNDROME 3	0.01237111	0.8997172872110444
#614976 CARPENTER SYNDROME 2; CRPT2	0.01237111	0.8997172872110444
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.01237111	0.8997172872110444
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.01234175	0.8975820140178941
#101200 APERT SYNDROME;;ACROCEPHALOSYNDACTYLY, TYPE I; ACS1;;ACS IAPERT-CROUZON DISEASE, INCLUDED;;ACROCEPHALOSYNDACTYLY, TYPE II, INCLUDED;;ACS II, INCLUDED;;VOGT CEPHALODACTYLY, INCLUDED	0.01183555	0.8607674605310823
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.01183555	0.8607674605310823
JOUBERT SYNDROME 35; JBTS35	0.01183555	0.8607674605310823
RAINE SYNDROME	0.01183555	0.8607674605310823
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.01183555	0.8607674605310823
HOLOPROSENCEPHALY 3; HPE3	0.01183555	0.8607674605310823
HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.01165865	0.8479020031786189
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.01165865	0.8479020031786189
COLE-CARPENTER SYNDROME 1; CLCRP1	0.01165865	0.8479020031786189
CRANIOLENTICULOSUTURAL DYSPLASIA	0.01165865	0.8479020031786189
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.01165865	0.8479020031786189
DYSOSTEOSCLEROSIS	0.01165865	0.8479020031786189
COLE-CARPENTER SYNDROME 2; CLCRP2	0.01165865	0.8479020031786189
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.01162929	0.8457667299854683
CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 2	0.01162929	0.8457667299854683
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.01162929	0.8457667299854683
#608747 INSULIN-LIKE GROWTH FACTOR I DEFICIENCY;;IGF1 DEFICIENCY;;GROWTH RETARDATION WITH SENSORINEURAL DEAFNESS AND MENTAL RETARDATION	0.01162929	0.8457667299854683
#612199 CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS; CRMCC;;COATS PLUS SYNDROME	0.01162929	0.8457667299854683
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.01162929	0.8457667299854683
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.01162929	0.8457667299854683
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.01162929	0.8457667299854683
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.01162929	0.8457667299854683
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.01157036	0.8414809108685624
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.01157036	0.8414809108685624
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.01157036	0.8414809108685624
ROBERTS SYNDROME; RBS	0.01157036	0.8414809108685624
MOWAT-WILSON SYNDROME; MOWS	0.01157036	0.8414809108685624
HUNTER-MACDONALD SYNDROME	0.01157036	0.8414809108685624
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.01157036	0.8414809108685624
THORACOABDOMINAL SYNDROME	0.01157036	0.8414809108685624
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.01157036	0.8414809108685624
ROIFMAN-CHITAYAT SYNDROME	0.01071948	0.7795987155488107
FACIOCARDIOMELIC SYNDROME	0.01071948	0.7795987155488107
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.01071948	0.7795987155488107
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.01071948	0.7795987155488107
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A	0.01071948	0.7795987155488107
#252500 MUCOLIPIDOSIS II ALPHA/BETA;;MUCOLIPIDOSIS II; ML II;;ML II ALPHA/BETA;;I-CELL DISEASE; ICD	0.01071948	0.7795987155488107
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.01071948	0.7795987155488107
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.01071948	0.7795987155488107
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.01071948	0.7795987155488107
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.01056992	0.7687216222665357
#150250 LARSEN SYNDROME; LRS	0.01056992	0.7687216222665357
CDAGS SYNDROME	0.00979853	0.7126205191172041
CRANIOFRONTONASAL SYNDROME; CFNS	0.00979853	0.7126205191172041
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.00979853	0.7126205191172041
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	0.00979853	0.7126205191172041
#305450 OPITZ-KAVEGGIA SYNDROME; OKS;;FG SYNDROME 1; FGS1;;FG SYNDROME; FGS;;MENTAL RETARDATION, LARGE HEAD, IMPERFORATE ANUS, CONGENITAL HYPOTONIA,AND PARTIAL AGENESIS OF CORPUS CALLOSUM;;KELLER SYNDROME	0.00979853	0.7126205191172041
#177980 PTERYGIA, MENTAL RETARDATION, AND DISTINCTIVE CRANIOFACIAL FEATURES;;HASPESLAGH SYNDROME	0.00979853	0.7126205191172041
MECKEL SYNDROME, TYPE 10; MKS10	0.00979853	0.7126205191172041
MEIER-GORLIN SYNDROME 3; MGORS3	0.00976917	0.7104852459240537
46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS; SERKAL	0.00976917	0.7104852459240537
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.00976917	0.7104852459240537
MARTINEZ-FRIAS SYNDROME	0.00976917	0.7104852459240537
#610198 3-@METHYLGLUTACONIC ACIDURIA, TYPE V; MGCA5;;CARDIOMYOPATHY, DILATED, WITH ATAXIA; DCMA;;MGA, TYPE V; MGA5	0.00976917	0.7104852459240537
MARDEN-WALKER SYNDROME	0.00976917	0.7104852459240537
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00976917	0.7104852459240537
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.00976917	0.7104852459240537
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.00976917	0.7104852459240537
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.00976917	0.7104852459240537
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.00976917	0.7104852459240537
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.00976917	0.7104852459240537
DUBOWITZ SYNDROME	0.00976917	0.7104852459240537
#194190 WOLF-HIRSCHHORN SYNDROME; WHS;;CHROMOSOME 4p16.3 DELETION SYNDROME;;PITT-ROGERS-DANKS SYNDROME; PRDS;;PITT SYNDROME	0.00976917	0.7104852459240537
#612626 CHROMOSOME 15q26-qter DELETION SYNDROME;;DRAYER SYNDROME	0.00976917	0.7104852459240537
SECKEL SYNDROME 1; SCKL1	0.00976917	0.7104852459240537
CHROMOSOME 10Q26 DELETION SYNDROME	0.00946413	0.6883005138110211
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.00946413	0.6883005138110211
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.00946413	0.6883005138110211
#602398 DESMOSTEROLOSIS	0.00946413	0.6883005138110211
#117550 SOTOS SYNDROME 1; SOTOS1;;SOTOS SYNDROME;;CEREBRAL GIGANTISM;;CHROMOSOME 5q35 DELETION SYNDROME	0.00946413	0.6883005138110211
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.00946413	0.6883005138110211
CHROMOSOME 1q21.1 DELETION SYNDROME, 1.35-MB	0.00946413	0.6883005138110211
NOONAN SYNDROME 3; NS3	0.00946413	0.6883005138110211
Myhre syndrome	0.00943477	0.6861652406178708
EMANUEL SYNDROME	0.00943477	0.6861652406178708
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.00943477	0.6861652406178708
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.00943477	0.6861652406178708
#612938 GROWTH RETARDATION, DEVELOPMENTAL DELAY, COARSE FACIES, AND EARLYDEATH; GDFD	0.00943477	0.6861652406178708
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ih; CDG1H	0.00943477	0.6861652406178708
KAPUR-TORIELLO SYNDROME	0.00943477	0.6861652406178708
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.00892857	0.649350687131059
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.00892857	0.649350687131059
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.00892857	0.649350687131059
WEYERS ULNAR RAY/OLIGODACTYLY SYNDROME	0.00892857	0.649350687131059
GENITOPATELLAR SYNDROME; GTPTS	0.00892857	0.649350687131059
258040 OEIS COMPLEX;;OMPHALOCELE-EXSTROPHY-IMPERFORATE ANUS-SPINAL DEFECTS	0.00892857	0.649350687131059
MESOMELIA-SYNOSTOSES SYNDROME	0.00892857	0.649350687131059
#222300 WOLFRAM SYNDROME 1; WFS1;;WFS;;DIABETES INSIPIDUS AND MELLITUS WITH OPTIC ATROPHY AND DEAFNESS; DIDMOAD	0.00892857	0.649350687131059
#613674 VESICOURETERAL REFLUX 3; VUR3	0.00892857	0.649350687131059
PRUNE BELLY SYNDROME WITH PULMONIC STENOSIS, MENTAL RETARDATION, ANDDEAFNESS	0.00892857	0.649350687131059
VISCERAL MYOPATHY; VSCM	0.00892857	0.649350687131059
XANTHINURIA, TYPE I	0.00892857	0.649350687131059
WEBB-DATTANI SYNDROME; WEDAS	0.00892857	0.649350687131059
SPONDYLOCOSTAL DYSOSTOSIS WITH ANAL ATRESIA AND UROGENITAL ANOMALIES	0.00892857	0.649350687131059
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.00892857	0.649350687131059
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.00892857	0.649350687131059
NODULI CUTANEI, MULTIPLE, WITH URINARY TRACT ABNORMALITIES	0.00892857	0.649350687131059
#143400 CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT 2;;URETEROPELVIC JUNCTION OBSTRUCTION; UPJO;;PELVIURETERIC JUNCTION OBSTRUCTION; PUJO;;HYDRONEPHROSIS DUE TO PUJO;;MULTICYSTIC RENAL DYSPLASIA, BILATERAL; MCRD	0.00892857	0.649350687131059
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.00892857	0.649350687131059
#608836 CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, ANTENATAL;;CPT II DEFICIENCY, LETHAL NEONATAL;;CPT2 DEFICIENCY, LETHAL NEONATAL	0.00892857	0.649350687131059
LETHAL CONGENITAL CONTRACTURE SYNDROME 2	0.00892857	0.649350687131059
UROFACIAL SYNDROME	0.00892857	0.649350687131059
DUANE-RADIAL RAY SYNDROME; DRRS	0.00892857	0.649350687131059
#260660 COUSIN SYNDROME;;CRANIOFACIAL DYSMORPHISM, HYPOPLASIA OF SCAPULA AND PELVIS, AND SHORTSTATURE;;PELVISCAPULAR DYSPLASIA	0.00892857	0.649350687131059
UROFACIAL SYNDROME 2	0.00892857	0.649350687131059
#304150 OCCIPITAL HORN SYNDROME; OHS;;CUTIS LAXA, X-LINKED, FORMERLY;;EHLERS-DANLOS SYNDROME, OCCIPITAL HORN TYPE, FORMERLY;;EDS IX, FORMERLY;;EDS9, FORMERLY	0.00892857	0.649350687131059
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT 3; CAKUT3	0.00892857	0.649350687131059
FRONTOMETAPHYSEAL DYSPLASIA	0.00892857	0.649350687131059
RENAL HYPODYSPLASIA/APLASIA 3; RHDA3	0.00892857	0.649350687131059
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.00892857	0.649350687131059
224250 DYSMYELINATION WITH JAUNDICE	0.00892857	0.649350687131059
2p15-16.1 microdeletion syndrome	0.00892857	0.649350687131059
OROFACIODIGITAL SYNDROME XV; OFD15	0.00892857	0.649350687131059
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.00892857	0.649350687131059
HIRSCHSPRUNG DISEASE WITH HYPOPLASTIC NAILS AND DYSMORPHIC FACIALFEATURES	0.00892857	0.649350687131059
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.00892857	0.649350687131059
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.00892857	0.649350687131059
FANCONI ANEMIA, COMPLEMENTATION GROUP O	0.00892857	0.649350687131059
TEEBI-SHALTOUT SYNDROME; TBSH	0.00892857	0.649350687131059
STROMME SYNDROME; STROMS	0.00892857	0.649350687131059
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.00892857	0.649350687131059
FOCAL DERMAL HYPOPLASIA; FDH	0.00892857	0.649350687131059
183802 SPLIT-HAND WITH OBSTRUCTIVE UROPATHY, SPINA BIFIDA, AND DIAPHRAGMATICDEFECTS	0.00892857	0.649350687131059
#129400 RAPP-HODGKIN SYNDROME; RHS;;ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH CLEFT LIP/PALATEOROFACIAL CLEFT 8, INCLUDED; OFC8, INCLUDED;;CLEFT LIP WITH OR WITHOUT CLEFT PALATE, NONSYNDROMIC, 8, INCLUDED	0.00885936	0.644317231487396
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.00885936	0.644317231487396
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.00885936	0.644317231487396
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.00885936	0.644317231487396
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.00885936	0.644317231487396
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.00885936	0.644317231487396
#219000 FRASER SYNDROME;;CRYPTOPHTHALMOS WITH OTHER MALFORMATIONSCRYPTOPHTHALMOS-SYNDACTYLY SYNDROME, INCLUDED	0.00885936	0.644317231487396
OCULOECTODERMAL SYNDROME; OES	0.00852496	0.619997226181213
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.00852496	0.619997226181213
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.00852496	0.619997226181213
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.00852496	0.619997226181213
WEILL-MARCHESANI SYNDROME 2; WMS2	0.00852496	0.619997226181213
WEILL-MARCHESANI SYNDROME 1; WMS1	0.00852496	0.619997226181213
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.00852496	0.619997226181213
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.00852496	0.619997226181213
SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	0.0078125	0.5681819421487874
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.0078125	0.5681819421487874
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.0078125	0.5681819421487874
#610915 OSTEOGENESIS IMPERFECTA, TYPE VIII; OI8;;OI, TYPE VIII	0.0078125	0.5681819421487874
CAMURATI-ENGELMANN DISEASE, TYPE 2	0.0078125	0.5681819421487874
HYPOGONADOTROPIC HYPOGONADISM 21 WITH OR WITHOUT ANOSMIA; HH21	0.0078125	0.5681819421487874
GERODERMA OSTEODYSPLASTICUM; GO	0.0078125	0.5681819421487874
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	0.0078125	0.5681819421487874
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.0078125	0.5681819421487874
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A	0.0078125	0.5681819421487874
#278250 WRINKLY SKIN SYNDROME; WSS	0.0078125	0.5681819421487874
#231050 GELEOPHYSIC DYSPLASIA 1; GPHYSD1	0.0078125	0.5681819421487874
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.0078125	0.5681819421487874
MULTICENTRIC CARPOTARSAL OSTEOLYSIS SYNDROME; MCTO	0.0078125	0.5681819421487874
BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 18	0.0078125	0.5681819421487874
OSTEOPETROSIS, AUTOSOMAL DOMINANT 3; OPTA3	0.0078125	0.5681819421487874
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0078125	0.5681819421487874
RHYNS SYNDROME; RHYNS	0.0078125	0.5681819421487874
#610539 GAUCHER DISEASE, ATYPICAL, DUE TO SAPOSIN C DEFICIENCY	0.0078125	0.5681819421487874
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.0078125	0.5681819421487874
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.0078125	0.5681819421487874
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.0078125	0.5681819421487874
CARDIOMYOPATHY, DILATED, WITH HYPERGONADOTROPIC HYPOGONADISM	0.0078125	0.5681819421487874
OSTEOGENESIS IMPERFECTA, TYPE XIX; OI19	0.0078125	0.5681819421487874
TENORIO SYNDROME; TNORS	0.0078125	0.5681819421487874
HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN	0.0078125	0.5681819421487874
HYPOGONADOTROPIC HYPOGONADISM 18 WITH OR WITHOUT ANOSMIA; HH18	0.0078125	0.5681819421487874
CALVARIAL DOUGHNUT LESIONS WITH BONE FRAGILITY; CDL	0.0078125	0.5681819421487874
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.0078125	0.5681819421487874
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.0078125	0.5681819421487874
#612714 EXOCRINE PANCREATIC INSUFFICIENCY, DYSERYTHROPOIETIC ANEMIA, AND CALVARIALHYPEROSTOSIS	0.0078125	0.5681819421487874
HYPERPARATHYROIDISM 4	0.0078125	0.5681819421487874
SCHINDLER DISEASE, TYPE I	0.0078125	0.5681819421487874
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.0078125	0.5681819421487874
OSTEOGENESIS IMPERFECTA, TYPE V	0.0078125	0.5681819421487874
264010 PRADER-WILLI HABITUS, OSTEOPENIA, AND CAMPTODACTYLY;;URBAN-ROGERS-MEYER SYNDROME	0.0078125	0.5681819421487874
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.0078125	0.5681819421487874
BRUCK SYNDROME 2	0.0078125	0.5681819421487874
NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 2	0.0078125	0.5681819421487874
EPIPHYSEAL CHONDRODYSPLASIA, MIURA TYPE; ECDM	0.0078125	0.5681819421487874
NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 1	0.0078125	0.5681819421487874
#615066 OSTEOGENESIS IMPERFECTA, TYPE XIV; OI14 ;;OI, TYPE XIV	0.0078125	0.5681819421487874
#614162 IMMUNODEFICIENCY 31C; IMD31C;;CANDIDIASIS, FAMILIAL, 7; CANDF7;;CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL DOMINANT	0.0078125	0.5681819421487874
ESTROGEN RESISTANCE; ESTRR	0.0078125	0.5681819421487874
%271530 BRACHYOLMIA TYPE 1, HOBAEK TYPE;;BRACHYOLMIA, RECESSIVE TYPE OF HOBAEK;;SPONDYLODYSPLASIA WITH PURE BRACHYOLMIA	0.0078125	0.5681819421487874
EXUDATIVE VITREORETINOPATHY 4	0.0078125	0.5681819421487874
OSTEOGENESIS IMPERFECTA, TYPE XVI; OI16	0.0078125	0.5681819421487874
GNATHODIAPHYSEAL DYSPLASIA; GDD	0.0078125	0.5681819421487874
HYALINE FIBROMATOSIS SYNDROME; HFS	0.0078125	0.5681819421487874
SPONDYLOOCULAR SYNDROME; SOS	0.0078125	0.5681819421487874
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.0078125	0.5681819421487874
HYPOGONADOTROPIC HYPOGONADISM 8 WITH OR WITHOUT ANOSMIA; HH8	0.0078125	0.5681819421487874
HYPOGONADOTROPIC HYPOGONADISM 19 WITH OR WITHOUT ANOSMIA; HH19	0.0078125	0.5681819421487874
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.0078125	0.5681819421487874
OSTEOGENESIS IMPERFECTA, TYPE I	0.0078125	0.5681819421487874
PRADER-WILLI SYNDROME; PWS	0.0078125	0.5681819421487874
JOINT LAXITY, SHORT STATURE, AND MYOPIA; JLSM	0.0078125	0.5681819421487874
DIAPHYSEAL MEDULLARY STENOSIS WITH MALIGNANT FIBROUS HISTIOCYTOMA; DMSMFH	0.0078125	0.5681819421487874
PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP	0.0078125	0.5681819421487874
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.0078125	0.5681819421487874
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.0078125	0.5681819421487874
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	0.0078125	0.5681819421487874
HYPOGONADOTROPIC HYPOGONADISM 20 WITH OR WITHOUT ANOSMIA; HH20	0.0078125	0.5681819421487874
OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	0.0078125	0.5681819421487874
HAMAMY SYNDROME; HMMS	0.0078125	0.5681819421487874
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.00766294	0.5573048488665124
138920 GRANDDAD SYNDROME;;GROWTH RETARDATION, AGED FACIES, NORMAL DEVELOPMENT, DECREASED SUBCUTANEOUSFAT, AUTOSOMAL DOMINANT INHERITANCE	0.00766294	0.5573048488665124
MEIER-GORLIN SYNDROME 1; MGORS1	0.00766294	0.5573048488665124
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.00766294	0.5573048488665124
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.00766294	0.5573048488665124
CHONDRODYSPLASIA WITH PLATYSPONDYLY, DISTINCTIVE BRACHYDACTYLY, HYDROCEPHALY, AND MICROPHTHALMIA	0.00766294	0.5573048488665124
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.00766294	0.5573048488665124
SHORT SYNDROME	0.00766294	0.5573048488665124
#264470 PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY;;STRAIGHT-CHAIN ACYL-CoA OXIDASE DEFICIENCY;;PSEUDONEONATAL ADRENOLEUKODYSTROPHY	0.0067531299999999995	0.49113683442985473
SMITH-KINGSMORE SYNDROME; SKS	0.0067531299999999995	0.49113683442985473
MEIER-GORLIN SYNDROME 6; MGORS6	0.0067531299999999995	0.49113683442985473
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.0067531299999999995	0.49113683442985473
MEMBRANOUS CRANIAL OSSIFICATION, DELAYED	0.0067531299999999995	0.49113683442985473
PELGER-HUET ANOMALY; PHA	0.0067531299999999995	0.49113683442985473
CHROMOSOME 16Q22 DELETION SYNDROME	0.0067531299999999995	0.49113683442985473
311450 PALLISTER W SYNDROME;;W SYNDROME	0.0067531299999999995	0.49113683442985473
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.0067531299999999995	0.49113683442985473
HYPOTONIA-CYSTINURIA SYNDROME	0.0067531299999999995	0.49113683442985473
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.0067531299999999995	0.49113683442985473
CLEIDOCRANIAL DYSPLASIA; CCD	0.0067531299999999995	0.49113683442985473
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.0067531299999999995	0.49113683442985473
FUMARASE DEFICIENCY; FMRD	0.0067531299999999995	0.49113683442985473
CHROMOSOME 1q41-q42 DELETION SYNDROME	0.0067531299999999995	0.49113683442985473
#252940 MUCOPOLYSACCHARIDOSIS, TYPE IIID; MPS3D;;MPS IIID;;SANFILIPPO SYNDROME D;;N-ACETYLGLUCOSAMINE-6-SULFATASE DEFICIENCY	0.0067531299999999995	0.49113683442985473
COFFIN-SIRIS SYNDROME 6; CSS6	0.0067531299999999995	0.49113683442985473
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.0067531299999999995	0.49113683442985473
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.0067531299999999995	0.49113683442985473
SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD	0.0067531299999999995	0.49113683442985473
HYPERTELORISM, TEEBI TYPE; TBHS	0.0067531299999999995	0.49113683442985473
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.0067531299999999995	0.49113683442985473
OPSISMODYSPLASIA; OPSMD	0.0067531299999999995	0.49113683442985473
THREE M SYNDROME 2; 3M2	0.0067531299999999995	0.49113683442985473
CRANIOFACIOFRONTODIGITAL SYNDROME	0.0067531299999999995	0.49113683442985473
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.0067531299999999995	0.49113683442985473
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.0067531299999999995	0.49113683442985473
POPOV-CHANG SYNDROME; POPCHAS	0.0067531299999999995	0.49113683442985473
MACROCEPHALY/AUTISM SYNDROME	0.0067531299999999995	0.49113683442985473
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.0067531299999999995	0.49113683442985473
268650 RUDIGER SYNDROME	0.0067531299999999995	0.49113683442985473
LAMB-SHAFFER SYNDROME	0.0067531299999999995	0.49113683442985473
GAPO SYNDROME; GAPOS	0.0067531299999999995	0.49113683442985473
JOUBERT SYNDROME 32; JBTS32	0.0067531299999999995	0.49113683442985473
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il; CDG1L	0.0067531299999999995	0.49113683442985473
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.0067531299999999995	0.49113683442985473
NASODIGITOACOUSTIC SYNDROME	0.0067531299999999995	0.49113683442985473
#108721 ATELOSTEOGENESIS, TYPE III; AOIII;;AO3	0.0067531299999999995	0.49113683442985473
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.0067531299999999995	0.49113683442985473
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.0067531299999999995	0.49113683442985473
SCLEROSTEOSIS 1; SOST1	0.0067531299999999995	0.49113683442985473
ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD10B	0.0067531299999999995	0.49113683442985473
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.0067531299999999995	0.49113683442985473
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.0067531299999999995	0.49113683442985473
#100800 ACHONDROPLASIA; ACH	0.0067531299999999995	0.49113683442985473
JOUBERT SYNDROME 2	0.0067531299999999995	0.49113683442985473
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.0067531299999999995	0.49113683442985473
#253250 MULIBREY NANISM;;MUSCLE-LIVER-BRAIN-EYE NANISM;;PERICARDIAL CONSTRICTION AND GROWTH FAILURE;;PERHEENTUPA SYNDROME	0.0067531299999999995	0.49113683442985473
OMODYSPLASIA 1; OMOD1	0.0067531299999999995	0.49113683442985473
#215100 RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1; RCDP1;;PEROXISOME BIOGENESIS DISORDER 9; PBD9;;CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC FORM; CDPR;;CHONDRODYSTROPHIA CALCIFICANS PUNCTATA	0.0067531299999999995	0.49113683442985473
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.0067237700000000004	0.48900156123670424
AL KAISSI SYNDROME; ALKAS	0.0067237700000000004	0.48900156123670424
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.0067237700000000004	0.48900156123670424
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.0067237700000000004	0.48900156123670424
DESBUQUOIS DYSPLASIA 2; DBQD2	0.0067237700000000004	0.48900156123670424
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.0067237700000000004	0.48900156123670424
DIAPHANOSPONDYLODYSOSTOSIS	0.0067237700000000004	0.48900156123670424
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.0067237700000000004	0.48900156123670424
COFFIN-SIRIS SYNDROME 5	0.0067237700000000004	0.48900156123670424
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.0067237700000000004	0.48900156123670424
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.0067237700000000004	0.48900156123670424
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.0067237700000000004	0.48900156123670424
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.0067237700000000004	0.48900156123670424
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.00595238	0.43290045808737265
191482 UNCOMBABLE HAIR, RETINAL PIGMENTARY DYSTROPHY, DENTAL ANOMALIES, ANDBRACHYDACTYLY;;BORK SYNDROME	0.00595238	0.43290045808737265
ELLIS-VAN CREVELD SYNDROME	0.00595238	0.43290045808737265
CHARGE-LIKE SYNDROME, X-LINKED	0.00595238	0.43290045808737265
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iy; CDG1Y	0.00595238	0.43290045808737265
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.00595238	0.43290045808737265
TOWNES-BROCKS SYNDROME 1; TBS1	0.00595238	0.43290045808737265
TONNE-KALSCHEUER SYNDROME; TOKAS	0.00595238	0.43290045808737265
#265000 MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT; EVMPS;;ESCOBAR SYNDROME;;MULTIPLE PTERYGIUM SYNDROME, NONLETHAL TYPE;;PTERYGIUM SYNDROME;;MULTIPLE PTERYGIUM SYNDROME;;PTERYGIUM COLLI SYNDROME;;PTERYGIUM UNIVERSALE	0.00595238	0.43290045808737265
MICROPHTHALMIA, SYNDROMIC 1	0.00595238	0.43290045808737265
N SYNDROME	0.00595238	0.43290045808737265
46,XX SEX REVERSAL 1; SRXX1	0.00595238	0.43290045808737265
DIAMOND-BLACKFAN ANEMIA 5	0.00595238	0.43290045808737265
PALMOPLANTAR HYPERKERATOSIS WITH SQUAMOUS CELL CARCINOMA OF SKIN AND 46,XX SEX REVERSAL	0.00595238	0.43290045808737265
601095 HARROD SYNDROME	0.00595238	0.43290045808737265
ANUS, IMPERFORATE	0.00595238	0.43290045808737265
BARDET-BIEDL SYNDROME 8; BBS8	0.00595238	0.43290045808737265
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00595238	0.43290045808737265
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.00595238	0.43290045808737265
#301830 SPINAL MUSCULAR ATROPHY, X-LINKED 2; SMAX2;;SPINAL MUSCULAR ATROPHY, X-LINKED LETHAL INFANTILE;;SPINAL MUSCULAR ATROPHY, INFANTILE X-LINKED; XLSMA;;ARTHROGRYPOSIS MULTIPLEX CONGENITA, DISTAL, X-LINKED;;AMC, DISTAL, X-LINKED;;ARTHROGRYPOSIS, X-LINKED, TYPE I; AMCX1	0.00595238	0.43290045808737265
603463 HYPOSPADIAS, HYPERTELORISM, UPPER LID COLOBOMA, AND MIXED-TYPE HEARINGLOSS	0.00595238	0.43290045808737265
46,XY SEX REVERSAL 6; SRXY6	0.00595238	0.43290045808737265
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE 2 DEFICIENCY	0.00595238	0.43290045808737265
#151100 LEOPARD SYNDROME 1;;LENTIGINOSIS, CARDIOMYOPATHIC;;MULTIPLE LENTIGINES SYNDROME	0.00595238	0.43290045808737265
METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA; METAG	0.00595238	0.43290045808737265
RENPENNING SYNDROME 1; RENS1	0.00595238	0.43290045808737265
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.00595238	0.43290045808737265
HAND-FOOT-GENITAL SYNDROME; HFG	0.00595238	0.43290045808737265
MENTAL RETARDATION, X-LINKED 106; MRX106	0.00595238	0.43290045808737265
KLEEFSTRA SYNDROME	0.00595238	0.43290045808737265
HARTSFIELD SYNDROME; HRTFDS	0.00595238	0.43290045808737265
HEMOLYTIC ANEMIA, LETHAL CONGENITAL NONSPHEROCYTIC, WITH GENITAL AND OTHER ABNORMALITIES	0.00595238	0.43290045808737265
HYPOGONADISM, MALEHYPOGONADISM AND TESTICULAR ATROPHY, INCLUDED	0.00595238	0.43290045808737265
RADIAL HYPOPLASIA, TRIPHALANGEAL THUMBS, HYPOSPADIAS, AND MAXILLARYDIASTEMA	0.00595238	0.43290045808737265
OTOONYCHOPERONEAL SYNDROME	0.00595238	0.43290045808737265
#300004 CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA;;ACC WITH ABNORMAL GENITALIA;;PROUD SYNDROME	0.00595238	0.43290045808737265
%146450 HYPOSPADIAS 3, AUTOSOMAL; HYSP3	0.00595238	0.43290045808737265
SECKEL SYNDROME 2; SCKL2	0.00595238	0.43290045808737265
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.00595238	0.43290045808737265
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.00595238	0.43290045808737265
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00595238	0.43290045808737265
RENAL CYSTS AND DIABETES SYNDROME; RCAD	0.00595238	0.43290045808737265
3MC SYNDROME 2	0.00595238	0.43290045808737265
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00595238	0.43290045808737265
MEIER-GORLIN SYNDROME 7	0.00595238	0.43290045808737265
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00595238	0.43290045808737265
TOWNES-BROCKS SYNDROME 2; TBS2	0.00595238	0.43290045808737265
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.00595238	0.43290045808737265
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.00595238	0.43290045808737265
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.00595238	0.43290045808737265
AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	0.00595238	0.43290045808737265
#194072 WILMS TUMOR, ANIRIDIA, GENITOURINARY ANOMALIES, AND MENTAL RETARDATIONSYNDROME; WAGR;;WAGR SYNDROME;;CHROMOSOME 11p13 DELETION SYNDROME	0.00595238	0.43290045808737265
#276820 ULNA AND FIBULA, ABSENCE OF, WITH SEVERE LIMB DEFICIENCY;;LIMB/PELVIS-HYPOPLASIA/APLASIA SYNDROME; LPHAS;;AL-AWADI/RAAS-ROTHSCHILD SYNDROME; AARRS;;SCHINZEL PHOCOMELIA SYNDROME	0.00595238	0.43290045808737265
LIPOID CONGENITAL ADRENAL HYPERPLASIA	0.00595238	0.43290045808737265
CREE MENTAL RETARDATION SYNDROME	0.00595238	0.43290045808737265
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	0.00595238	0.43290045808737265
GENITOPALATOCARDIAC SYNDROME	0.00595238	0.43290045808737265
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.00595238	0.43290045808737265
LAMBERT SYNDROME	0.00595238	0.43290045808737265
#309801 MICROPHTHALMIA, SYNDROMIC 7; MCOPS7;;MICROPHTHALMIA WITH LINEAR SKIN DEFECTS; MLS;;MICROPHTHALMIA, DERMAL APLASIA, AND SCLEROCORNEA;;MIDAS SYNDROME	0.00595238	0.43290045808737265
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.00595238	0.43290045808737265
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.00595238	0.43290045808737265
BARDET-BIEDL SYNDROME 6; BBS6	0.00595238	0.43290045808737265
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.00561798	0.4085804527811897
ZIMMERMANN-LABAND SYNDROME 1	0.00561798	0.4085804527811897
LATERAL MENINGOCELE SYNDROME	0.00561798	0.4085804527811897
CAYLER CARDIOFACIAL SYNDROME	0.00561798	0.4085804527811897
%601612 LUNG AGENESIS, CONGENITAL HEART DEFECTS, AND THUMB ANOMALIES SYNDROME;LACHT;;MARDINI-NYHAN ASSOCIATION	0.00561798	0.4085804527811897
CHAR SYNDROME	0.00561798	0.4085804527811897
%241310 HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS	0.00561798	0.4085804527811897
DIAMOND-BLACKFAN ANEMIA 6; DBA6	0.00561798	0.4085804527811897
#615382 NEPHRONOPHTHISIS 16; NPHP16	0.00561798	0.4085804527811897
MESOAXIAL HEXADACTYLY AND CARDIAC MALFORMATION	0.00561798	0.4085804527811897
PATENT DUCTUS ARTERIOSUS 1	0.00561798	0.4085804527811897
HEMIFACIAL MICROSOMIA	0.00561798	0.4085804527811897
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.00561798	0.4085804527811897
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.00561798	0.4085804527811897
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.00561798	0.4085804527811897
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.00561798	0.4085804527811897
#615297 ADAMS-OLIVER SYNDROME 4; AOS4	0.00561798	0.4085804527811897
FEINGOLD SYNDROME 1; FGLDS1	0.00561798	0.4085804527811897
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.00561798	0.4085804527811897
AORTIC ANEURYSM, FAMILIAL THORACIC 4	0.00561798	0.4085804527811897
#267010 MECKEL SYNDROME, TYPE 7; MKS7;;RENAL-HEPATIC-PANCREATIC DYSPLASIA WITH DANDY-WALKER CYST;;GOLDSTON SYNDROME	0.00561798	0.4085804527811897
604381 PATENT DUCTUS ARTERIOSUS AND BICUSPID AORTIC VALVE WITH HAND ANOMALIES	0.00561798	0.4085804527811897
PHACE ASSOCIATION	0.00561798	0.4085804527811897
PATENT DUCTUS ARTERIOSUS 3	0.00561798	0.4085804527811897
NOONAN SYNDROME 8; NS8	0.00561798	0.4085804527811897
DIAMOND-BLACKFAN ANEMIA 10	0.00561798	0.4085804527811897
#300049 HETEROTOPIA, PERIVENTRICULAR, X-LINKED DOMINANT;;HETEROTOPIA, FAMILIAL NODULAR;;PERIVENTRICULAR NODULAR HETEROTOPIA 1; PVNH1;;NODULAR HETEROTOPIA, BILATERAL PERIVENTRICULAR; NHBP; BPNHHETEROTOPIA, PERIVENTRICULAR NODULAR, WITH FRONTOMETAPHYSEAL DYSPLASIA,INCLUDED	0.00561798	0.4085804527811897
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.00561798	0.4085804527811897
Mental retardation, autosomal dominant 21	0.00561798	0.4085804527811897
C SYNDROME	0.00561798	0.4085804527811897
#614432 VENTRICULAR SEPTAL DEFECT 3; VSD3	0.00561798	0.4085804527811897
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.00561798	0.4085804527811897
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.00561798	0.4085804527811897
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.00561798	0.4085804527811897
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.00561798	0.4085804527811897
OROFACIODIGITAL SYNDROME XIV; OFD14	0.00561798	0.4085804527811897
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.00561798	0.4085804527811897
#610168 LOEYS-DIETZ SYNDROME 2; LDS2;;AORTIC ANEURYSM, FAMILIAL THORACIC 3; AAT3;;MARFAN SYNDROME, TYPE II, FORMERLY	0.00561798	0.4085804527811897
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.00561798	0.4085804527811897
HETEROTAXY, VISCERAL, 1, X-LINKED; HTX1	0.00561798	0.4085804527811897
BARAITSER-WINTER SYNDROME 1; BRWS1	0.00561798	0.4085804527811897
DISTICHIASIS WITH CONGENITAL ANOMALIES OF THE HEART AND PERIPHERAL	0.00561798	0.4085804527811897
RETINAL DYSTROPHY, IRIS COLOBOMA, AND COMEDOGENIC ACNE SYNDROME	0.00561798	0.4085804527811897
PSEUDO-TORCH SYNDROME 2	0.00561798	0.4085804527811897
FANCONI ANEMIA, COMPLEMENTATION GROUP U	0.00561798	0.4085804527811897
#208540 RENAL-HEPATIC-PANCREATIC DYSPLASIA; RHPD	0.00561798	0.4085804527811897
CARDIAC-UROGENITAL SYNDROME; CUGS	0.00561798	0.4085804527811897
PHELAN-MCDERMID SYNDROME; PHMDS	0.00561798	0.4085804527811897
LOEYS-DIETZ SYNDROME 3; LDS3	0.00561798	0.4085804527811897
#602482 AXENFELD-RIEGER SYNDROME, TYPE 3; RIEG3;;AXENFELD-RIEGER ANOMALY WITH OR WITHOUT CARDIAC DEFECTS AND/OR SENSORINEURALHEARING LOSS;;ANTERIOR SEGMENT MESENCHYMAL DYSGENESIS;;ANTERIOR CHAMBER CLEAVAGE SYNDROME;;RIEGER SYNDROME, TYPE 3AXENFELD ANOMALY, INCLUDED;;RIEGER ANOMALY, INCLUDED;;AXENFELD-RIEGER ANOMALY, INCLUDED	0.00561798	0.4085804527811897
HOLT-ORAM SYNDROME	0.00561798	0.4085804527811897
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.00561798	0.4085804527811897
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.00561798	0.4085804527811897
SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY; SRTD13	0.00561798	0.4085804527811897
LEFT VENTRICULAR NONCOMPACTION 1; LVNC1	0.00561798	0.4085804527811897
PATENT DUCTUS ARTERIOSUS 2	0.00561798	0.4085804527811897
#163950 NOONAN SYNDROME 1; NS1;;NOONAN SYNDROME;;MALE TURNER SYNDROME;;FEMALE PSEUDO-TURNER SYNDROME;;TURNER PHENOTYPE WITH NORMAL KARYOTYPEPTERYGIUM COLLI SYNDROME, INCLUDED	0.00561798	0.4085804527811897
CHROMOSOME 13q14 DELETION SYNDROME	0.00384615	0.2797200610298315
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.00384615	0.2797200610298315
ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH T-CELL IMMUNODEFICIENCY, AUTOSOMAL DOMINANT	0.00384615	0.2797200610298315
DEAFNESS-CRANIOFACIAL SYNDROME	0.00384615	0.2797200610298315
Miller-Dieker syndrome (MDS)	0.00384615	0.2797200610298315
CRANIOECTODERMAL DYSPLASIA 3	0.00384615	0.2797200610298315
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00384615	0.2797200610298315
#613603 CHROMOSOME 4q32.1-q32.2 TRIPLICATION SYNDROME	0.00384615	0.2797200610298315
#269921 SIALURIA;;SIALURIA, FRENCH TYPE	0.00384615	0.2797200610298315
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.00384615	0.2797200610298315
#612475 CHROMOSOME 1q21.1 DUPLICATION SYNDROME	0.00384615	0.2797200610298315
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.00384615	0.2797200610298315
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.00384615	0.2797200610298315
RUIJS-AALFS SYNDROME; RJALS	0.00384615	0.2797200610298315
HAREL-YOON SYNDROME; HAYOS	0.00384615	0.2797200610298315
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.00384615	0.2797200610298315
CLARK-BARAITSER SYNDROME	0.00384615	0.2797200610298315
CHROMOSOME 19p13.13 DELETION SYNDROME	0.00384615	0.2797200610298315
#230500 GM1-GANGLIOSIDOSIS, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, INFANTILE FORM;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 1;;BETA-GALACTOSIDASE-1 DEFICIENCY;;GLB1 DEFICIENCYGM1-GANGLIOSIDOSIS, TYPE I, WITH CARDIAC INVOLVEMENT, INCLUDED;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I, WITH CARDIAC INVOLVEMENT,INCLUDED	0.00384615	0.2797200610298315
GLASS SYNDROME	0.00384615	0.2797200610298315
TEMTAMY SYNDROME; TEMTYS	0.00384615	0.2797200610298315
Rothmund-Thomson syndrome	0.00384615	0.2797200610298315
#300640 INVASIVE PNEUMOCOCCAL DISEASE, RECURRENT ISOLATED, 2; IPD2	0.00384615	0.2797200610298315
JOUBERT SYNDROME 10	0.00384615	0.2797200610298315
SCHAAF-YANG SYNDROME; SHFYNG	0.00384615	0.2797200610298315
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.00384615	0.2797200610298315
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.00384615	0.2797200610298315
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.00384615	0.2797200610298315
CHONDRODYSPLASIA PUNCTATA, AUTOSOMAL DOMINANTCHONDRODYSPLASIA PUNCTATA DUE TO VITAMIN K DEFICIENCY, INCLUDED	0.00384615	0.2797200610298315
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.00384615	0.2797200610298315
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.00384615	0.2797200610298315
#230000 FUCOSIDOSIS;;ALPHA-L-FUCOSIDASE DEFICIENCY	0.00384615	0.2797200610298315
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.00384615	0.2797200610298315
CINCA SYNDROME; CINCA	0.00384615	0.2797200610298315
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.00384615	0.2797200610298315
HYPOCHONDROPLASIA	0.00384615	0.2797200610298315
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.00384615	0.2797200610298315
#603387 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME;MPPH;;MEGALENCEPHALY, POLYMICROGYRIA, MEGA CORPUS CALLOSUM SYNDROME;;MEG-PMG-MEGACC SYNDROME;;MEGALENCEPHALY, MEGA CORPUS CALLOSUM, AND COMPLETE LACK OF MOTOR DEVELOPMENT	0.00384615	0.2797200610298315
#309520 LUJAN-FRYNS SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH MARFANOID HABITUS	0.00384615	0.2797200610298315
MEESTER-LOEYS SYNDROME; MRLS	0.00384615	0.2797200610298315
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.00384615	0.2797200610298315
JOUBERT SYNDROME 26	0.00384615	0.2797200610298315
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.00384615	0.2797200610298315
GLYCEROL KINASE DEFICIENCY; GKD	0.00384615	0.2797200610298315
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.00384615	0.2797200610298315
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.00384615	0.2797200610298315
#602875 ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE; AMDMST. HELENA DYSPLASIA, INCLUDED	0.00384615	0.2797200610298315
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.00384615	0.2797200610298315
OROFACIODIGITAL SYNDROME I; OFD1	0.00384615	0.2797200610298315
#615085 OSTEOPETROSIS, AUTOSOMAL RECESSIVE 8; OPTB8	0.00384615	0.2797200610298315
#156200 MENTAL RETARDATION, AUTOSOMAL DOMINANT 1; MRD1CHROMOSOME 2q23.1 DELETION SYNDROME, INCLUDED	0.00384615	0.2797200610298315
WAISMAN SYNDROME; WSMN	0.00384615	0.2797200610298315
BASAL CELL NEVUS SYNDROME	0.00384615	0.2797200610298315
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.00384615	0.2797200610298315
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00384615	0.2797200610298315
PYCNODYSOSTOSIS	0.00384615	0.2797200610298315
PSEUDODIASTROPHIC DYSPLASIA	0.00384615	0.2797200610298315
SCHIZOPHRENIA 1; SCZD1	0.00384615	0.2797200610298315
SCLEROSTEOSIS 2; SOST2	0.00384615	0.2797200610298315
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.00384615	0.2797200610298315
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.00384615	0.2797200610298315
LARSEN-LIKE SYNDROME	0.00384615	0.2797200610298315
CHROMOSOME 4q21 DELETION SYNDROME	0.00384615	0.2797200610298315
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.00384615	0.2797200610298315
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00384615	0.2797200610298315
FORSYTHE-WAKELING SYNDROME; FWS	0.00384615	0.2797200610298315
#311300 OTOPALATODIGITAL SYNDROME, TYPE I; OPD1;;OPD I SYNDROME;;OPD SYNDROME 1OTOPALATODIGITAL SPECTRUM DISORDER, INCLUDED;;FRONTOOTOPALATODIGITAL OSTEODYSPLASIA, INCLUDED	0.00384615	0.2797200610298315
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.00384615	0.2797200610298315
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.00384615	0.2797200610298315
#300676 MENTAL RETARDATION, X-LINKED, SYNDROMIC 14; MRXS14	0.00384615	0.2797200610298315
CRANIOECTODERMAL DYSPLASIA 4	0.00384615	0.2797200610298315
MACROCEPHALY, BENIGN FAMILIAL	0.00384615	0.2797200610298315
RENAL AND MULLERIAN DUCT HYPOPLASIA	0.00384615	0.2797200610298315
ANIRIDIA, PARTIAL, WITH UNILATERAL RENAL AGENESIS AND PSYCHOMOTORRETARDATION	0.00384615	0.2797200610298315
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.00384615	0.2797200610298315
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.00384615	0.2797200610298315
HYPOPHOSPHATASIA, CHILDHOOD	0.00384615	0.2797200610298315
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.00384615	0.2797200610298315
108450 ASYMMETRIC SHORT STATURE SYNDROME	0.00384615	0.2797200610298315
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.00384615	0.2797200610298315
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.00384615	0.2797200610298315
THANATOPHORIC DYSPLASIA, TYPE I	0.00384615	0.2797200610298315
OROFACIODIGITAL SYNDROME V; OFD5	0.00384615	0.2797200610298315
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.00384615	0.2797200610298315
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.00384615	0.2797200610298315
CEREBROOCULONASAL SYNDROME	0.00384615	0.2797200610298315
CROUZON SYNDROME	0.00384615	0.2797200610298315
%193250 VOLVULUS OF MIDGUT;;INTESTINAL MALROTATION, FAMILIAL	0.00384615	0.2797200610298315
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.00384615	0.2797200610298315
HOLOPROSENCEPHALY 7	0.00384615	0.2797200610298315
COLOBOMA, OSTEOPETROSIS, MICROPHTHALMIA, MACROCEPHALY, ALBINISM, AND DEAFNESS; COMMAD	0.00384615	0.2797200610298315
Retinitis pigmentosa with or without skeletal anomalies	0.00384615	0.2797200610298315
ATKIN-FLAITZ SYNDROME	0.00384615	0.2797200610298315
ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V; IGHD5	0.00384615	0.2797200610298315
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.00384615	0.2797200610298315
300064 MENTAL RETARDATION, X-LINKED, WITH CRANIOFACIAL DYSMORPHISM;;MENTAL RETARDATION, X-LINKED, HYDE-FORSTER TYPE	0.00384615	0.2797200610298315
CRANIOECTODERMAL DYSPLASIA 1	0.00384615	0.2797200610298315
311895 PIERRE ROBIN SEQUENCE WITH FACIAL AND DIGITAL ANOMALIES	0.00384615	0.2797200610298315
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.00384615	0.2797200610298315
TRICHODENTOOSSEOUS SYNDROME	0.00384615	0.2797200610298315
CRANIOSYNOSTOSIS 2	0.00384615	0.2797200610298315
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.00384615	0.2797200610298315
CRANIOSYNOSTOSIS 4; CRS4	0.00384615	0.2797200610298315
#614205 THREE M SYNDROME 3; 3M3;;3@M SYNDROME 3	0.00384615	0.2797200610298315
MENTAL RETARDATION, X-LINKED 93	0.00384615	0.2797200610298315
236410 HUMERORADIAL SYNOSTOSIS WITH CRANIOFACIAL ANOMALIES	0.00384615	0.2797200610298315
INFANTILE LIVER FAILURE SYNDROME 1	0.00384615	0.2797200610298315
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.00384615	0.2797200610298315
HEMOCHROMATOSIS, NEONATAL	0.00381679	0.277584787836681
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.00381679	0.277584787836681
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix; CDG1X	0.00381679	0.277584787836681
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.00381679	0.277584787836681
#246200 DONOHUE SYNDROME;;LEPRECHAUNISMINSULIN RECEPTOR, DEFECT IN, INCLUDED	0.00381679	0.277584787836681
HOLOPROSENCEPHALY WITH FETAL AKINESIA/HYPOKINESIA SEQUENCE	0.00381679	0.277584787836681
#269000 SC PHOCOMELIA SYNDROME;;SC PSEUDOTHALIDOMIDE SYNDROME	0.00381679	0.277584787836681
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.00381679	0.277584787836681
DIABETES MELLITUS, TRANSIENT NEONATAL, 1; TNDM1	0.00381679	0.277584787836681
#613804 MEIER-GORLIN SYNDROME 4; MGORS4	0.00381679	0.277584787836681
236640 HYDROCEPHALUS WITH ASSOCIATED MALFORMATIONS	0.00381679	0.277584787836681
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.00381679	0.277584787836681
DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE	0.00381679	0.277584787836681
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.00381679	0.277584787836681
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.00381679	0.277584787836681
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.00381679	0.277584787836681
Trichothiodystrophy 5, nonphotosensitive	0.00381679	0.277584787836681
MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE); MTDPS15	0.00381679	0.277584787836681
SAUL-WILSON SYNDROME; SWILS	0.00381679	0.277584787836681
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K	0.00381679	0.277584787836681
IMMUNODEFICIENCY 55; IMD55	0.00381679	0.277584787836681
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.00381679	0.277584787836681
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.00381679	0.277584787836681
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.00381679	0.277584787836681
#610758 CEREBROOCULOFACIOSKELETAL SYNDROME 4; COFS4	0.00381679	0.277584787836681
MEIER-GORLIN SYNDROME 8; MGORS8	0.00381679	0.277584787836681
CHROMOSOME 22q11.2 DELETION SYNDROME, DISTAL	0.00381679	0.277584787836681
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.00381679	0.277584787836681
REVESZ SYNDROME	0.00381679	0.277584787836681
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.00381679	0.277584787836681
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.00381679	0.277584787836681
MECKEL SYNDROME, TYPE 4; MKS4	0.00381679	0.277584787836681
VERVERI-BRADY SYNDROME; VERBRAS	0.00381679	0.277584787836681
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.00381679	0.277584787836681
FILIPPI SYNDROME; FLPIS	0.00381679	0.277584787836681
#270100 HETEROTAXY, VISCERAL, 5, AUTOSOMAL; HTX5;;SITUS INVERSUS VISCERUM; SIV	0.00381679	0.277584787836681
SECKEL SYNDROME 7; SCKL7	0.00381679	0.277584787836681
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.00381679	0.277584787836681
#133540 COCKAYNE SYNDROME, TYPE B; CSB;;CKN2	0.00381679	0.277584787836681
WARSAW BREAKAGE SYNDROME; WABS	0.00381679	0.277584787836681
#603358 GRACILE SYNDROME;;GROWTH RETARDATION, AMINO ACIDURIA, CHOLESTASIS, IRON OVERLOAD, LACTICACIDOSIS, AND EARLY DEATH;;FINNISH LETHAL NEONATAL METABOLIC SYNDROME; FLNMS;;LACTIC ACIDOSIS, FINNISH, WITH HEPATIC HEMOSIDEROSIS;;FELLMAN SYNDROME	0.00381679	0.277584787836681
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.00381679	0.277584787836681
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L	0.00381679	0.277584787836681
RUSSELL-SILVER SYNDROME, X-LINKED	0.00381679	0.277584787836681
SECKEL SYNDROME 4	0.00381679	0.277584787836681
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.00381679	0.277584787836681
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.00381679	0.277584787836681
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00381679	0.277584787836681
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.00381679	0.277584787836681
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.00381679	0.277584787836681
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.00381679	0.277584787836681
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.00381679	0.277584787836681
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.00381679	0.277584787836681
#615665 JOUBERT SYNDROME 22; JBTS22	0.00381679	0.277584787836681
#613370 MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 10; MODY10	0.00381679	0.277584787836681
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.00381679	0.277584787836681
#614815 JOUBERT SYNDROME 18; JBTS18	0.00381679	0.277584787836681
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.00381679	0.277584787836681
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.00381679	0.277584787836681
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.00381679	0.277584787836681
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.00381679	0.277584787836681
LETHAL CONGENITAL CONTRACTURE SYNDROME 10; LCCS10	0.00381679	0.277584787836681
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.00381679	0.277584787836681
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.00381679	0.277584787836681
LAMBOTTE SYNDROME	0.00381679	0.277584787836681
PREECLAMPSIA/ECLAMPSIA 1	0.00381679	0.277584787836681
RETINITIS PIGMENTOSA 59; RP59	0.00381679	0.277584787836681
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.00381679	0.277584787836681
#603194 MECKEL SYNDROME, TYPE 2; MKS2;;MECKEL-GRUBER SYNDROME, TYPE 2	0.00381679	0.277584787836681
AICARDI-GOUTIERES SYNDROME 7	0.00381679	0.277584787836681
CHROMOSOME 1p35 DELETION SYNDROME	0.00381679	0.277584787836681
#300867 KABUKI SYNDROME 2; KABUK2	0.00381679	0.277584787836681
COCKAYNE SYNDROME A; CSA	0.00381679	0.277584787836681
LOWRY-MACLEAN SYNDROME	0.00381679	0.277584787836681
CATEL-MANZKE SYNDROME; CATMANS	0.00381679	0.277584787836681
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.00381679	0.277584787836681
PYRUVATE KINASE DEFICIENCY OF RED CELLS	0.00381679	0.277584787836681
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.00381679	0.277584787836681
#244460 KENNY-CAFFEY SYNDROME, TYPE 1; KCS1;;KCS;;KENNY-CAFFEY SYNDROME, AUTOSOMAL RECESSIVE	0.00381679	0.277584787836681
NEU-LAXOVA SYNDROME 2; NLS2	0.00381679	0.277584787836681
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.00381679	0.277584787836681
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.00381679	0.277584787836681
GABRIELE-DE VRIES SYNDROME; GADEVS	0.00381679	0.277584787836681
#609054 FANCONI ANEMIA, COMPLEMENTATION GROUP J; FANCJ	0.00381679	0.277584787836681
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.00381679	0.277584787836681
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.00381679	0.277584787836681
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.00381679	0.277584787836681
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.00381679	0.277584787836681
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.00381679	0.277584787836681
FINGER LOCKING, RECURRENT, WITH INTRAUTERINE GROWTH RETARDATION ANDPROPORTIONATE SHORT STATURE	0.00381679	0.277584787836681
GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID	0.00381679	0.277584787836681
MITCHELL-RILEY SYNDROME; MTCHRS	0.00381679	0.277584787836681
#253290 MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS;;PTERYGIUM SYNDROME, MULTIPLE, LETHAL TYPE	0.00381679	0.277584787836681
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.00381679	0.277584787836681
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.00381679	0.277584787836681
#609060 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1; COXPD1;;HEPATOENCEPHALOPATHY, EARLY FATAL PROGRESSIVE	0.00381679	0.277584787836681
Mulchandani-Bhoj-Conlin syndrome	0.00381679	0.277584787836681
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.00381679	0.277584787836681
TRICHOHEPATOENTERIC SYNDROME 2	0.00381679	0.277584787836681
MECKEL SYNDROME 12; MKS12	0.00381679	0.277584787836681
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.00381679	0.277584787836681
SECKEL SYNDROME 9; SCKL9	0.00381679	0.277584787836681
BARTSOCAS-PAPAS SYNDROME; BPS	0.00381679	0.277584787836681
#260370 PANCREATIC AGENESIS, CONGENITAL; PAGEN;;PANCREATIC HYPOPLASIA, CONGENITAL	0.00381679	0.277584787836681
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00381679	0.277584787836681
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.00381679	0.277584787836681
BOHRING-OPITZ SYNDROME	0.00381679	0.277584787836681
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00381679	0.277584787836681
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.00381679	0.277584787836681
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.00381679	0.277584787836681
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.00381679	0.277584787836681
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.00381679	0.277584787836681
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.00381679	0.277584787836681
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.00381679	0.277584787836681
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.00381679	0.277584787836681
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.00381679	0.277584787836681
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.00381679	0.277584787836681
MEIER-GORLIN SYNDROME 5; MGORS5	0.00381679	0.277584787836681
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.00381679	0.277584787836681
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.00381679	0.277584787836681
HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 4; HNFJ4	0.00381679	0.277584787836681
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.00381679	0.277584787836681
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.00381679	0.277584787836681
MEIER-GORLIN SYNDROME 2; MGORS2	0.00381679	0.277584787836681
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.00381679	0.277584787836681
CHROMOSOME Xq27.3-q28 DUPLICATION SYNDROME	0.00381679	0.277584787836681
#256050 ATELOSTEOGENESIS, TYPE II; AOII;;AO2;;NEONATAL OSSEOUS DYSPLASIA IDE LA CHAPELLE DYSPLASIA, INCLUDED; DLCD, INCLUDED	0.00290698	0.21141677340002327
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME; NPLCS	0.00290698	0.21141677340002327
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.00290698	0.21141677340002327
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.00290698	0.21141677340002327
ALAZAMI SYNDROME; ALAZS	0.00290698	0.21141677340002327
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.00290698	0.21141677340002327
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.00290698	0.21141677340002327
Xq28 (MECP2) duplication	0.00290698	0.21141677340002327
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00290698	0.21141677340002327
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.00290698	0.21141677340002327
ADAMS-OLIVER SYNDROME 2; AOS2	0.00290698	0.21141677340002327
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	0.00290698	0.21141677340002327
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.00290698	0.21141677340002327
CHROMOSOME 3pter-p25 DELETION SYNDROME	0.00290698	0.21141677340002327
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.00290698	0.21141677340002327
#613707 LEOPARD SYNDROME 3; LPRD3	0.00290698	0.21141677340002327
COFFIN-SIRIS SYNDROME 7; CSS7	0.00290698	0.21141677340002327
113470 BRACHYMESOMELIA-RENAL SYNDROME	0.00290698	0.21141677340002327
#609528 CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMASYNDROME;;CEDNIK SYNDROME	0.00290698	0.21141677340002327
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.00290698	0.21141677340002327
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.00290698	0.21141677340002327
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.00290698	0.21141677340002327
KEUTEL SYNDROME; KTLS	0.00290698	0.21141677340002327
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.00290698	0.21141677340002327
#610829 HOLOPROSENCEPHALY 9; HPE9;;PITUITARY ANOMALIES WITH HOLOPROSENCEPHALY-LIKE FEATURES;;HOLOPROSENCEPHALY WITH MICROPHTHALMIA AND FIRST BRANCHIAL ARCH ANOMALIES	0.00290698	0.21141677340002327
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.00290698	0.21141677340002327
ALAGILLE SYNDROME 1; ALGS1	0.00290698	0.21141677340002327
RADIAL RAY HYPOPLASIA WITH CHOANAL ATRESIA	0.00290698	0.21141677340002327
STICKLER SYNDROME, TYPE I	0.00290698	0.21141677340002327
#103580 PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A;;PHP IA;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITH MULTIPLE HORMONE RESISTANCE	0.00290698	0.21141677340002327
CALVARIAL HYPEROSTOSIS	0.00290698	0.21141677340002327
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.00290698	0.21141677340002327
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.00290698	0.21141677340002327
MUCOPOLYSACCHARIDOSIS TYPE IX	0.00290698	0.21141677340002327
PROTEUS SYNDROME	0.00290698	0.21141677340002327
KYPHOMELIC DYSPLASIA	0.00290698	0.21141677340002327
FRONTONASAL DYSPLASIA 2; FND2	0.00290698	0.21141677340002327
#101800 ACRODYSOSTOSIS 1, WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS1;;ADOHR	0.00290698	0.21141677340002327
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00290698	0.21141677340002327
#300895 OHDO SYNDROME, X-LINKED; OHDOX;;BLEPHAROPHIMOSIS-MENTAL RETARDATION SYNDROME, MAAT-KIEVIT-BRUNNERTYPE	0.00290698	0.21141677340002327
#612462 PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C;;PHP IC	0.00290698	0.21141677340002327
CHROMOSOME 2q37 DELETION SYNDROME	0.00290698	0.21141677340002327
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.00290698	0.21141677340002327
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00290698	0.21141677340002327
SONODA SYNDROME	0.00290698	0.21141677340002327
GLUTAMINE DEFICIENCY, CONGENITAL	0.00290698	0.21141677340002327
MOEBIUS SYNDROME; MBS	0.00290698	0.21141677340002327
XIA-GIBBS SYNDROME	0.00290698	0.21141677340002327
#154780 MARSHALL SYNDROME; MRSHS	0.00290698	0.21141677340002327
#609242 KANZAKI DISEASE;;ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, TYPE II;;ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, ADULT-ONSET;;NAGA DEFICIENCY, TYPE II;;SCHINDLER DISEASE, TYPE II	0.00290698	0.21141677340002327
OROFACIODIGITAL SYNDROME XVI; OFD16	0.00290698	0.21141677340002327
#612463 PSEUDOPSEUDOHYPOPARATHYROIDISM; PPHP;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITHOUT MULTIPLE HORMONE RESISTANCE	0.00290698	0.21141677340002327
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.00290698	0.21141677340002327
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.00290698	0.21141677340002327
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.00290698	0.21141677340002327
HURLER SYNDROME	0.00290698	0.21141677340002327
RING CHROMOSOME 14 SYNDROME	0.00290698	0.21141677340002327
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.00290698	0.21141677340002327
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.00290698	0.21141677340002327
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.00290698	0.21141677340002327
Congenital disorder of glycosylation, type IIh	0.00290698	0.21141677340002327
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.00290698	0.21141677340002327
#215140 GREENBERG DYSPLASIA; GRBGD;;HYDROPS-ECTOPIC CALCIFICATION-MOTH-EATEN SKELETAL DYSPLASIA;;HEM SKELETAL DYSPLASIA;;MOTH-EATEN SKELETAL DYSPLASIA;;CHONDRODYSTROPHY, HYDROPIC AND PRENATALLY LETHAL TYPE	0.00290698	0.21141677340002327
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.00290698	0.21141677340002327
MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD	0.00290698	0.21141677340002327
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.00290698	0.21141677340002327
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00290698	0.21141677340002327
AYME-GRIPP SYNDROME; AYGRP	0.00290698	0.21141677340002327
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.00290698	0.21141677340002327
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.00290698	0.21141677340002327
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.00290698	0.21141677340002327
#614069 IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME2; ICF2	0.00290698	0.21141677340002327
SCHEIE SYNDROME	0.00290698	0.21141677340002327
HEART AND BRAIN MALFORMATION SYNDROME	0.00290698	0.21141677340002327
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.00290698	0.21141677340002327
#162100 AMYOTROPHY, HEREDITARY NEURALGIC; HNA;;NEURITIS WITH BRACHIAL PREDILECTION; NAPB;;BRACHIAL PLEXUS NEUROPATHY, HEREDITARY;;AMYOTROPHY, HEREDITARY NEURALGIC, WITH PREDILECTION FOR BRACHIAL PLEXUS	0.00290698	0.21141677340002327
MARTSOLF SYNDROME	0.00290698	0.21141677340002327
#608027 PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3;;CEREBELLAR ATROPHY WITH PROGRESSIVE MICROCEPHALY; CLAM;;PCH WITH OPTIC ATROPHY	0.00290698	0.21141677340002327
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.00290698	0.21141677340002327
#615503 SHORT RIB-POLYDACTYLY SYNDROME, TYPE VI; SRPS6	0.00290698	0.21141677340002327
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.00290698	0.21141677340002327
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.00290698	0.21141677340002327
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CDG1D	0.00290698	0.21141677340002327
TEMPLE-BARAITSER SYNDROME; TMBTS	0.00290698	0.21141677340002327
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.00290698	0.21141677340002327
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.00290698	0.21141677340002327
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.00290698	0.21141677340002327
#300868 MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2; MCAHS2	0.00290698	0.21141677340002327
#616006 HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 2; HKLLS2	0.00290698	0.21141677340002327
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.00290698	0.21141677340002327
CHITAYAT SYNDROME	0.00290698	0.21141677340002327
OROFACIODIGITAL SYNDROME X	0.00290698	0.21141677340002327
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.00290698	0.21141677340002327
#200600 ACHONDROGENESIS, TYPE IA; ACG1A;;ACHONDROGENESIS, HOUSTON-HARRIS TYPE	0.00290698	0.21141677340002327
EHLERS-DANLOS SYNDROME, TYPE VI	0.00290698	0.21141677340002327
#611554 LEOPARD SYNDROME 2	0.00290698	0.21141677340002327
NOONAN SYNDROME 4; NS4	0.00290698	0.21141677340002327
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.00290698	0.21141677340002327
NOONAN SYNDROME 7; NS7	0.00290698	0.21141677340002327
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.00290698	0.21141677340002327
%265300 LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL;;LYMPHANGIOMATOSIS, PULMONARY;;PULMONARY CYSTIC LYMPHANGIECTASIS	0.00290698	0.21141677340002327
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.00290698	0.21141677340002327
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.00290698	0.21141677340002327
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.00290698	0.21141677340002327
CODAS SYNDROME	0.00290698	0.21141677340002327
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.00290698	0.21141677340002327
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.00290698	0.21141677340002327
HOLOPROSENCEPHALY 5; HPE5	0.00290698	0.21141677340002327
CRISPONI/COLD-INDUCED SWEATING SYNDROME 3; CISS3	0.00290698	0.21141677340002327
#232400 GLYCOGEN STORAGE DISEASE III;;GSD III; GSD3;;FORBES DISEASE;;CORI DISEASE;;LIMIT DEXTRINOSIS;;AMYLO-1,6-GLUCOSIDASE DEFICIENCY;;AGL DEFICIENCY;;GLYCOGEN DEBRANCHER DEFICIENCY;;GDE DEFICIENCYGLYCOGEN STORAGE DISEASE IIIa, INCLUDED; GSD IIIa, INCLUDED;;GLYCOGEN STORAGE DISEASE IIIb, INCLUDED; GSD IIIb, INCLUDED;;GLYCOGEN STORAGE DISEASE IIIc, INCLUDED; GSD IIIc, INCLUDED;;GLYCOGEN STORAGE DISEASE IIId, INCLUDED; GSD IIId, INCLUDED	0.00290698	0.21141677340002327
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.00290698	0.21141677340002327
MENTAL RETARDATION, X-LINKED 9	0.00290698	0.21141677340002327
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.00290698	0.21141677340002327
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.00290698	0.21141677340002327
VAN BOGAERT-HOZAY SYNDROME	0.00290698	0.21141677340002327
NOONAN SYNDROME 5; NS5	0.00290698	0.21141677340002327
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.00290698	0.21141677340002327
NOONAN SYNDROME 11; NS11	0.00290698	0.21141677340002327
STICKLER SYNDROME, TYPE II	0.00290698	0.21141677340002327
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.00290698	0.21141677340002327
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.00290698	0.21141677340002327
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.00290698	0.21141677340002327
SCALP-EAR-NIPPLE SYNDROME; SENS	0.00290698	0.21141677340002327
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.00290698	0.21141677340002327
#222448 DONNAI-BARROW SYNDROME;;FACIOOCULOACOUSTICORENAL SYNDROME;;DBS/FOAR SYNDROME;;DIAPHRAGMATIC HERNIA, EXOMPHALOS, ABSENT CORPUS CALLOSUM, HYPERTELORISM,MYOPIA, SENSORINEURAL DEAFNESS, AND PROTEINURIA	0.00290698	0.21141677340002327
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.00290698	0.21141677340002327
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.00290698	0.21141677340002327
DESANTO-SHINAWI SYNDROME	0.00290698	0.21141677340002327
%155050 MAXILLONASAL DYSPLASIA, BINDER TYPE;;BINDER SYNDROME	0.00290698	0.21141677340002327
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.00290698	0.21141677340002327
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.00290698	0.21141677340002327
JABERI-ELAHI SYNDROME; JABELS	0.00290698	0.21141677340002327
#156550 KNIEST DYSPLASIA	0.00290698	0.21141677340002327
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.00290698	0.21141677340002327
NOONAN SYNDROME 6; NS6	0.00290698	0.21141677340002327
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.00290698	0.21141677340002327
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.00290698	0.21141677340002327
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.00290698	0.21141677340002327
OGDEN SYNDROME; OGDNS	0.00290698	0.21141677340002327
FACIAL ECTODERMAL DYSPLASIA	0.00290698	0.21141677340002327
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.00290698	0.21141677340002327
ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE; ECTD13	0.00290698	0.21141677340002327
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.00290698	0.21141677340002327
BARATELA-SCOTT SYNDROME	0.00290698	0.21141677340002327
HOLOPROSENCEPHALY 4	0.00290698	0.21141677340002327
#300860 MENTAL RETARDATION, X-LINKED, SYNDROMIC, NASCIMENTO TYPE; MRXSN;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 30; MRXS30	0.00290698	0.21141677340002327
ASPARTYLGLUCOSAMINURIA; AGU	0.00290698	0.21141677340002327
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.00290698	0.21141677340002327
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.00290698	0.21141677340002327
WEAVER SYNDROME	0.00290698	0.21141677340002327
#101600 PFEIFFER SYNDROME;;ACROCEPHALOSYNDACTYLY, TYPE V; ACS5;;ACS V;;NOACK SYNDROMECRANIOFACIAL-SKELETAL-DERMATOLOGIC DYSPLASIA, INCLUDED	0.00290698	0.21141677340002327
DESBUQUOIS DYSPLASIA 1	0.00290698	0.21141677340002327
#609597 PARIETAL FORAMINA 2; PFM2	0.00290698	0.21141677340002327
